dnase i  (Worthington Biochemical)


Bioz Verified Symbol Worthington Biochemical is a verified supplier
Bioz Manufacturer Symbol Worthington Biochemical manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Name:
    Deoxyribonuclease I
    Description:
    Chromatographically purified A lyophilized powder with glycine as a stabilizer
    Catalog Number:
    ls002004
    Price:
    33
    Size:
    5 mg
    Source:
    Bovine Pancreas
    Cas Number:
    9003.98.9
    Buy from Supplier


    Structured Review

    Worthington Biochemical dnase i
    Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of <t>DNase</t> I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).
    Chromatographically purified A lyophilized powder with glycine as a stabilizer
    https://www.bioz.com/result/dnase i/product/Worthington Biochemical
    Average 99 stars, based on 431 article reviews
    Price from $9.99 to $1999.99
    dnase i - by Bioz Stars, 2020-11
    99/100 stars

    Images

    1) Product Images from "Structural and functional conservation at the boundaries of the chicken ?-globin domain"

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    Journal: The EMBO Journal

    doi: 10.1093/emboj/19.10.2315

    Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).
    Figure Legend Snippet: Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).

    Techniques Used: Derivative Assay

    Fig. 4.  Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with  Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from  Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.
    Figure Legend Snippet: Fig. 4. Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.

    Techniques Used: End Labeling, Migration, Derivative Assay, Mutagenesis

    Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.
    Figure Legend Snippet: Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.

    Techniques Used: Southern Blot, Hybridization, Isolation, Derivative Assay

    Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.
    Figure Legend Snippet: Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.

    Techniques Used: Blocking Assay, Activity Assay, Stable Transfection, Transfection, Construct, Expressing

    2) Product Images from "Structural and functional conservation at the boundaries of the chicken ?-globin domain"

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    Journal: The EMBO Journal

    doi: 10.1093/emboj/19.10.2315

    Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).
    Figure Legend Snippet: Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).

    Techniques Used: Derivative Assay

    Fig. 4.  Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with  Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from  Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.
    Figure Legend Snippet: Fig. 4. Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.

    Techniques Used: End Labeling, Migration, Derivative Assay, Mutagenesis

    Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.
    Figure Legend Snippet: Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.

    Techniques Used: Southern Blot, Hybridization, Isolation, Derivative Assay

    Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.
    Figure Legend Snippet: Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.

    Techniques Used: Blocking Assay, Activity Assay, Stable Transfection, Transfection, Construct, Expressing

    3) Product Images from "A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro"

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro

    Journal: Journal of Virology

    doi:

    DNase I footprinting of protein bound to the I1L promoter. I1L promoter 120-nucleotide DNA uniquely labeled on the template (A) or nontemplate (B) strand was treated with DNase I in the absence (lanes 1) or presence (lanes 2) of glycerol gradient-purified LPBP. Cleavage products were resolved on a 6% polyacrylamide DNA sequencing gel. Lanes 3 contain probe DNA chemically cleaved at purine residues. The nucleotide sequence of each strand of the I1L promoter is shown on the right.
    Figure Legend Snippet: DNase I footprinting of protein bound to the I1L promoter. I1L promoter 120-nucleotide DNA uniquely labeled on the template (A) or nontemplate (B) strand was treated with DNase I in the absence (lanes 1) or presence (lanes 2) of glycerol gradient-purified LPBP. Cleavage products were resolved on a 6% polyacrylamide DNA sequencing gel. Lanes 3 contain probe DNA chemically cleaved at purine residues. The nucleotide sequence of each strand of the I1L promoter is shown on the right.

    Techniques Used: Footprinting, Labeling, Purification, DNA Sequencing, Sequencing

    4) Product Images from "Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting"

    Article Title: Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting

    Journal: PLoS Genetics

    doi: 10.1371/journal.pgen.0020160

    Transcription Factor Binding and Nucleosome Depletion at the Human GRP78 Promoter (A) ChIP analysis of the GRP78 promoter was performed on noninduced or TG-induced LD419 cells using antibodies against TBP, RNA polII, NF-Y, total H3, and acetylated H3-K9/14. Precipitated DNA was quantified by real-time PCR using primers specific for the indicated four regions of the promoter. The enrichment at each region is plotted as percentage of input. The data are representatives of experiments performed from two or three independent chromatin preparations. (B, C) MNase assay. (B) A mixture of oligonucleosomes (lane 2) from LD419 nuclei digested with MNase was fractionated through a sucrose gradient to obtain mononucleosomal, dinucleosomal, and trinucleosomal DNA (lanes 4, 5, and 6). Purified genomic DNA partially digested with MNase was used as naked DNA control (D1 and D2, lanes 7 and 8; M in lanes 1 and 9 indicates size marker). (C) Relative enrichment of nucleosomal and naked DNA at four regions of the GRP78 promoter. The values plotted are normalized with respect to the value at the R1 region, arbitrarily defined as 1. The four regions are depicted on the promoter diagram at the top of the figure. The TATA box (T), TIS (bent arrow), and ERSEs (E1–E3) are marked. (D) DNase I hypersensitivity assay. Top: EtBr staining. Bottom: Southern blot. The assay was performed on nuclei extracted from noninduced or TG-induced cells. Genomic DNA was included as a control to show a lack of sequence specificity of the enzyme. DNase I–digested samples were resolved by gel electrophoresis, showing varying extents of digestion (EtBr staining). Southern blot performed after RsaI digestion revealed a hypersensitive region in the GRP78 promoter similar in size in both noninduced and induced samples. On the left, a map of the GRP78 promoter region is shown indicating the 1,802-bp DNA fragment generated by RsaI digestion, transcription start site (bent arrow), and probe fragment (black box). Numbers next to the marker indicate size in bp.
    Figure Legend Snippet: Transcription Factor Binding and Nucleosome Depletion at the Human GRP78 Promoter (A) ChIP analysis of the GRP78 promoter was performed on noninduced or TG-induced LD419 cells using antibodies against TBP, RNA polII, NF-Y, total H3, and acetylated H3-K9/14. Precipitated DNA was quantified by real-time PCR using primers specific for the indicated four regions of the promoter. The enrichment at each region is plotted as percentage of input. The data are representatives of experiments performed from two or three independent chromatin preparations. (B, C) MNase assay. (B) A mixture of oligonucleosomes (lane 2) from LD419 nuclei digested with MNase was fractionated through a sucrose gradient to obtain mononucleosomal, dinucleosomal, and trinucleosomal DNA (lanes 4, 5, and 6). Purified genomic DNA partially digested with MNase was used as naked DNA control (D1 and D2, lanes 7 and 8; M in lanes 1 and 9 indicates size marker). (C) Relative enrichment of nucleosomal and naked DNA at four regions of the GRP78 promoter. The values plotted are normalized with respect to the value at the R1 region, arbitrarily defined as 1. The four regions are depicted on the promoter diagram at the top of the figure. The TATA box (T), TIS (bent arrow), and ERSEs (E1–E3) are marked. (D) DNase I hypersensitivity assay. Top: EtBr staining. Bottom: Southern blot. The assay was performed on nuclei extracted from noninduced or TG-induced cells. Genomic DNA was included as a control to show a lack of sequence specificity of the enzyme. DNase I–digested samples were resolved by gel electrophoresis, showing varying extents of digestion (EtBr staining). Southern blot performed after RsaI digestion revealed a hypersensitive region in the GRP78 promoter similar in size in both noninduced and induced samples. On the left, a map of the GRP78 promoter region is shown indicating the 1,802-bp DNA fragment generated by RsaI digestion, transcription start site (bent arrow), and probe fragment (black box). Numbers next to the marker indicate size in bp.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction, Purification, Marker, Staining, Southern Blot, Sequencing, Nucleic Acid Electrophoresis, Generated

    5) Product Images from "Prefoldin-Nascent Chain Complexes in the Folding of Cytoskeletal Proteins "

    Article Title: Prefoldin-Nascent Chain Complexes in the Folding of Cytoskeletal Proteins

    Journal: The Journal of Cell Biology

    doi:

    The actin–PFD complex forms cotranslationally. Reticulocyte lysate was programmed with mRNA encoding either a 336– or a 257–amino acid NH 2 -terminal fragment of actin. After 8 min, edeine and 7- Me GMP were added, and the reaction continued for an additional 9 min. Nascent chain–ribosome complexes were stabilized by addition of 0.5 mM cycloheximide, and polysomes isolated by gradient centrifugation. Aliquots from each fraction were incubated with puromycin to release nascent chains from the ribosome. (A and B) SDS-PAGE and native-PAGE analyses of the gradient fractions obtained from the 336–amino acid actin translation product. S denotes the starting material for the gradient. Shown are fluorograms of the gels with molecular mass markers on the left. The position of sedimentation of the standards catalase (11.3 S) and α2-macroglobulin (18.6 S) are indicated at the bottom of A. (C) The proteins in the starting material for the gradient and each of the gradient fractions were analyzed for their content of CCT by an immunoblot using anti-CCT antibodies. (D) The polysome-bound actin complex contains PFD. The purified polysomes shown in A and B (lane 7) were treated with puromycin and apyrase, and then incubated at 4°C for 30 min with immobilized preimmune antibody, immobilized PFD antibody, or DNase I coupled to Sepharose 4B. After clarification, the supernatant fractions from each of the reactions were analyzed by native-PAGE (top). The antibody beads were washed four times with PBS and the material retained by the beads was eluted by heating in Laemmli sample buffer, then analyzed by SDS-PAGE (bottom). The starting material is shown in lane 1; immobilized preimmune antibodies, lane 2; immobilized anti-PFD antibody, lane 3; immobilized DNase I, lane 4. The position of actin PFD is indicated on the left. (E and F) SDS-PAGE and native-PAGE analysis of the gradient fractions obtained from the 257–amino acid actin translation product, performed as in A and B. S denotes the starting material for the gradient which was immediately frozen while S′ denotes the starting material which was stored at 4°C during the centrifugation run.
    Figure Legend Snippet: The actin–PFD complex forms cotranslationally. Reticulocyte lysate was programmed with mRNA encoding either a 336– or a 257–amino acid NH 2 -terminal fragment of actin. After 8 min, edeine and 7- Me GMP were added, and the reaction continued for an additional 9 min. Nascent chain–ribosome complexes were stabilized by addition of 0.5 mM cycloheximide, and polysomes isolated by gradient centrifugation. Aliquots from each fraction were incubated with puromycin to release nascent chains from the ribosome. (A and B) SDS-PAGE and native-PAGE analyses of the gradient fractions obtained from the 336–amino acid actin translation product. S denotes the starting material for the gradient. Shown are fluorograms of the gels with molecular mass markers on the left. The position of sedimentation of the standards catalase (11.3 S) and α2-macroglobulin (18.6 S) are indicated at the bottom of A. (C) The proteins in the starting material for the gradient and each of the gradient fractions were analyzed for their content of CCT by an immunoblot using anti-CCT antibodies. (D) The polysome-bound actin complex contains PFD. The purified polysomes shown in A and B (lane 7) were treated with puromycin and apyrase, and then incubated at 4°C for 30 min with immobilized preimmune antibody, immobilized PFD antibody, or DNase I coupled to Sepharose 4B. After clarification, the supernatant fractions from each of the reactions were analyzed by native-PAGE (top). The antibody beads were washed four times with PBS and the material retained by the beads was eluted by heating in Laemmli sample buffer, then analyzed by SDS-PAGE (bottom). The starting material is shown in lane 1; immobilized preimmune antibodies, lane 2; immobilized anti-PFD antibody, lane 3; immobilized DNase I, lane 4. The position of actin PFD is indicated on the left. (E and F) SDS-PAGE and native-PAGE analysis of the gradient fractions obtained from the 257–amino acid actin translation product, performed as in A and B. S denotes the starting material for the gradient which was immediately frozen while S′ denotes the starting material which was stored at 4°C during the centrifugation run.

    Techniques Used: Isolation, Gradient Centrifugation, Incubation, SDS Page, Clear Native PAGE, Sedimentation, Purification, Clarification Assay, Centrifugation

    Actin species I contains PFD. (A) HeLa cell lysate or rabbit reticulocyte lysate was examined for content of PFD 6 by SDS-PAGE and Western blot analysis. Lane 1, HeLa cells grown at 37°C; lane 2, HeLa cells 12 h after a 43°C/60 min heat shock treatment; lane 3, rabbit reticulocyte lysate. The position of PFD 6 is shown on the right of the panel. (B) Purified bovine PFD (lane 1) and in vitro translated [ 35 S]methionine-labeled actin (lane 2) were analyzed by native-PAGE, the proteins transferred to nitrocellulose, and the position of purified PFD was determined by immunoblot using the PFD 6 antibody. After extensive washing, the nitrocellulose was placed on film and the position of actin species I and II revealed by autoradiography. The positions of actin species I and II are indicated on the right. (C) Identification of actin-containing complex components by electrophoretic mobility shift assays. Full-length actin mRNA (left) was translated for 15 and 50 min. The reactions were mixed together to create a pool of all actin-containing species. The mRNA encoding 336–amino acid actin was translated for 30 min (right). Before native-PAGE analysis, equal aliquots of the reaction mixtures were incubated with: PBS (control, lane 1); preimmune antiserum (lane 2); anti–PFD 6 serum (lane 3); anti–PFD 6 serum supplemented with purified actin (lane 4); purified anti-CCT mAb (lane 5); and DNase I (lane 6). DNase shift (lane 6) was omitted for the 336–amino acid actin translation products. The different protein complexes were then analyzed by native-PAGE. A fluorogram of the gel is shown. Molecular mass markers are shown at the left, and the positions of the different actin complexes are indicated in the center. The arrowhead indicates the shift in full-length actin migration due to the presence of actin-binding proteins present in the crude rabbit antisera. (D and F) Identification of actin-containing complex components by immunodepletion with immobilized antichaperone specific antibodies and DNase I. The full-length [ 35 S]methionine-labeled actin translation reaction products (C) were incubated with antichaperone antibodies first bound to protein A–Sepharose, or with DNase I coupled to Affigel-10. After incubation, the samples were clarified and the corresponding supernatants analyzed for the presence of the different actin species by native-PAGE as shown in D. In parallel, the corresponding pellets containing the immobilized antibodies or DNase I were resuspended in Laemmli sample buffer and analyzed for their relative content of radiolabeled actin by SDS-PAGE as shown in F. An aliquot of the in vitro translation products (i.e., starting material) is shown in lane 1; protein A–Sepharose, lane 2; immobilized preimmune antibodies, lane 3; PFD 6 antibody, lane 4; anti-CCT antibody, lane 5; immobilized DNase, lane 6. The positions of the different actin complexes are indicated in the center. (E and G) The [ 35 S]methionine-labeled 336–amino acid actin translation reaction products (C) were incubated with the immobilized antichaperone antibodies or immobilized DNase. Subsequently, the samples were clarified and the supernatants and pellets analyzed by native-PAGE and SDS-PAGE, respectively. Lane designations are the same as in D and F.
    Figure Legend Snippet: Actin species I contains PFD. (A) HeLa cell lysate or rabbit reticulocyte lysate was examined for content of PFD 6 by SDS-PAGE and Western blot analysis. Lane 1, HeLa cells grown at 37°C; lane 2, HeLa cells 12 h after a 43°C/60 min heat shock treatment; lane 3, rabbit reticulocyte lysate. The position of PFD 6 is shown on the right of the panel. (B) Purified bovine PFD (lane 1) and in vitro translated [ 35 S]methionine-labeled actin (lane 2) were analyzed by native-PAGE, the proteins transferred to nitrocellulose, and the position of purified PFD was determined by immunoblot using the PFD 6 antibody. After extensive washing, the nitrocellulose was placed on film and the position of actin species I and II revealed by autoradiography. The positions of actin species I and II are indicated on the right. (C) Identification of actin-containing complex components by electrophoretic mobility shift assays. Full-length actin mRNA (left) was translated for 15 and 50 min. The reactions were mixed together to create a pool of all actin-containing species. The mRNA encoding 336–amino acid actin was translated for 30 min (right). Before native-PAGE analysis, equal aliquots of the reaction mixtures were incubated with: PBS (control, lane 1); preimmune antiserum (lane 2); anti–PFD 6 serum (lane 3); anti–PFD 6 serum supplemented with purified actin (lane 4); purified anti-CCT mAb (lane 5); and DNase I (lane 6). DNase shift (lane 6) was omitted for the 336–amino acid actin translation products. The different protein complexes were then analyzed by native-PAGE. A fluorogram of the gel is shown. Molecular mass markers are shown at the left, and the positions of the different actin complexes are indicated in the center. The arrowhead indicates the shift in full-length actin migration due to the presence of actin-binding proteins present in the crude rabbit antisera. (D and F) Identification of actin-containing complex components by immunodepletion with immobilized antichaperone specific antibodies and DNase I. The full-length [ 35 S]methionine-labeled actin translation reaction products (C) were incubated with antichaperone antibodies first bound to protein A–Sepharose, or with DNase I coupled to Affigel-10. After incubation, the samples were clarified and the corresponding supernatants analyzed for the presence of the different actin species by native-PAGE as shown in D. In parallel, the corresponding pellets containing the immobilized antibodies or DNase I were resuspended in Laemmli sample buffer and analyzed for their relative content of radiolabeled actin by SDS-PAGE as shown in F. An aliquot of the in vitro translation products (i.e., starting material) is shown in lane 1; protein A–Sepharose, lane 2; immobilized preimmune antibodies, lane 3; PFD 6 antibody, lane 4; anti-CCT antibody, lane 5; immobilized DNase, lane 6. The positions of the different actin complexes are indicated in the center. (E and G) The [ 35 S]methionine-labeled 336–amino acid actin translation reaction products (C) were incubated with the immobilized antichaperone antibodies or immobilized DNase. Subsequently, the samples were clarified and the supernatants and pellets analyzed by native-PAGE and SDS-PAGE, respectively. Lane designations are the same as in D and F.

    Techniques Used: SDS Page, Western Blot, Purification, In Vitro, Labeling, Clear Native PAGE, Autoradiography, Electrophoretic Mobility Shift Assay, Incubation, Migration, Binding Assay

    6) Product Images from "Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression"

    Article Title: Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gkp261

    Mapping of the BMP-2-induced DNase I hypersensitivity within the proximal FGFR3 promoter. C3H10T1/2 cells were treated with or without 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with increasing concentrations of DNase I (0, 1, 3, 5 U/ml) and DNA was purified and cleaved with Nco I. After Southern blotting, the filter was hybridized with the 32 P-labeled probe used in the MNase digestion assay. The DNase I-hypersensitive sites are indicated by arrowheads. As a control, purified genomic DNA from C3H10T1/2 cells was digested in vitro with increasing concentrations of DNase I. Size markers were generated as described in ‘Material and Methods’ section. The diagrams at the right of each panel indicate the positions of the transcription start site and the probes used for hybridization (solid bars). The large signal near +1 in the figure on the left is an autoradiograph artifact.
    Figure Legend Snippet: Mapping of the BMP-2-induced DNase I hypersensitivity within the proximal FGFR3 promoter. C3H10T1/2 cells were treated with or without 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with increasing concentrations of DNase I (0, 1, 3, 5 U/ml) and DNA was purified and cleaved with Nco I. After Southern blotting, the filter was hybridized with the 32 P-labeled probe used in the MNase digestion assay. The DNase I-hypersensitive sites are indicated by arrowheads. As a control, purified genomic DNA from C3H10T1/2 cells was digested in vitro with increasing concentrations of DNase I. Size markers were generated as described in ‘Material and Methods’ section. The diagrams at the right of each panel indicate the positions of the transcription start site and the probes used for hybridization (solid bars). The large signal near +1 in the figure on the left is an autoradiograph artifact.

    Techniques Used: Purification, Southern Blot, Labeling, In Vitro, Generated, Hybridization, Autoradiography

    Alteration in the restriction enzyme accessibility at the FGFR3 proximal promoter induced by BMP-2 treatment. ( A ) C3H10T1/2 cells were incubated in the presence or absence of 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with 25–200 U of restriction enzyme/ml, and purified DNA was digested to completion with Nco I. Products were detected by Southern blotting (top panel). A tentative assignment of the nucleosome positions in this region based on nuclease digestion is shown and is aligned with the nuclease-hypersensitive sites. Sites of cutting by DNase I and MNase and restriction enzyme are depicted by solid bars for basal conditions. Because MNase preferentially digests DNA in linker regions between nucleosomes, it is possible to locate nucleosomes within the FGFR3 proximal promoter. Hollow arrow heads indicate increases in the nuclease hypersensitivity upon BMP-2 exposure. ( B ) The relative nuclease sensitivity of restriction enzyme sites was quantitated, and the intensities of the radioactive bands were used to calculate the percentage of DNA digested. All the results are the means of three independent experiments ± standard deviation. * P
    Figure Legend Snippet: Alteration in the restriction enzyme accessibility at the FGFR3 proximal promoter induced by BMP-2 treatment. ( A ) C3H10T1/2 cells were incubated in the presence or absence of 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with 25–200 U of restriction enzyme/ml, and purified DNA was digested to completion with Nco I. Products were detected by Southern blotting (top panel). A tentative assignment of the nucleosome positions in this region based on nuclease digestion is shown and is aligned with the nuclease-hypersensitive sites. Sites of cutting by DNase I and MNase and restriction enzyme are depicted by solid bars for basal conditions. Because MNase preferentially digests DNA in linker regions between nucleosomes, it is possible to locate nucleosomes within the FGFR3 proximal promoter. Hollow arrow heads indicate increases in the nuclease hypersensitivity upon BMP-2 exposure. ( B ) The relative nuclease sensitivity of restriction enzyme sites was quantitated, and the intensities of the radioactive bands were used to calculate the percentage of DNA digested. All the results are the means of three independent experiments ± standard deviation. * P

    Techniques Used: Incubation, Purification, Southern Blot, Standard Deviation

    Inducible DNase I hypersensitivity within the FGFR3 promoter. ( A ) Schematic representation of the probe used to map the DNase-hypersensitive sites within the FGFR3 promoter by the indirect end-labeling technique. ( B ) C3H10T1/2 cells were treated with or without 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with increasing concentrations of DNase I (0, 1, 3, 5 U/ml). DNA was purified and cleaved with Hind III. After Southern blotting, the filter was hybridized with the 32 P-labeled probe. The DNase I-hypersensitive sites are indicated by arrowheads. As a control, purified genomic DNA from C3H10T1/2 cells was digested in vitro with increasing concentrations of DNase I (0, 0.05, 0.1, 0.2 U/ml).
    Figure Legend Snippet: Inducible DNase I hypersensitivity within the FGFR3 promoter. ( A ) Schematic representation of the probe used to map the DNase-hypersensitive sites within the FGFR3 promoter by the indirect end-labeling technique. ( B ) C3H10T1/2 cells were treated with or without 200 ng/ml BMP-2 with 5% FBS for 1 day. Nuclei were then purified and digested with increasing concentrations of DNase I (0, 1, 3, 5 U/ml). DNA was purified and cleaved with Hind III. After Southern blotting, the filter was hybridized with the 32 P-labeled probe. The DNase I-hypersensitive sites are indicated by arrowheads. As a control, purified genomic DNA from C3H10T1/2 cells was digested in vitro with increasing concentrations of DNase I (0, 0.05, 0.1, 0.2 U/ml).

    Techniques Used: End Labeling, Purification, Southern Blot, Labeling, In Vitro

    7) Product Images from "Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells"

    Article Title: Characterization of the survival motor neuron (SMN) promoter provides evidence for complex combinatorial regulation in undifferentiated and differentiated P19 cells

    Journal:

    doi: 10.1042/BJ20041024

    Summary of in vivo DMS, UVC and DNase I footprints of the mouse Smn proximal promoter
    Figure Legend Snippet: Summary of in vivo DMS, UVC and DNase I footprints of the mouse Smn proximal promoter

    Techniques Used: In Vivo

    8) Product Images from "Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿ §"

    Article Title: Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿Dynamic BRG1 Recruitment during T Helper Differentiation and Activation Reveals Distal Regulatory Elements ▿ §

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.00920-10

    Novel BRG1 binding sites in the Gata3 locus are in open chromatin and possess enhancer-like activity. (A, B, and C) Distal BRG1 binding sites have an open chromatin conformation. Nuclei from stimulated Th1 and Th2 cells were digested with DNase I; DNA was quantified using Q-PCR primers detecting the indicated regions. For each region, a representative dose response is shown; similar results were obtained by averaging three biological replicates digested with 8 μg/ml DNase I (data not shown). (A) Distal BRG1 binding regions are DHS in Th2 cells but not in Th1 cells. (B) Control regions lacking BRG1 binding are not DHS. (C) A control region with BRG1 binding in Th1 and Th2 cells is DHS in both. (D and E) Distal BRG1 binding sites possess enhancer-like activity. The indicated elements were placed immediately upstream (D) or 2.2 kb downstream (E) of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). (F) Enhancer-like activity is BRG1 dependent. The indicated elements were placed upstream of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. Cells were treated with BRG1 shRNA or a control, as indicated. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). (G) Distal BRG1 binding sites lack enhancer-like activity in a nonepisomal vector. The indicated elements were placed upstream of the SV40 promoter in the pGL3 promoter vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. The horizontal line at 1 on the y axis indicates the value obtained with the promoter alone. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). These same elements exhibited increased expression using episomal reporters (D and E). None of the five tested regions were positive for enhancer-like activity in this assay. (H) Distal regions without BRG1 binding in Th2 cells lack enhancer-like activity. The indicated elements were placed upstream of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with stimulation. The horizontal line at 1 on the y axis indicates the value obtained with the promoter alone. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values. All four tested regions lacking BRG1 binding were negative for enhancer-like activity in this assay.
    Figure Legend Snippet: Novel BRG1 binding sites in the Gata3 locus are in open chromatin and possess enhancer-like activity. (A, B, and C) Distal BRG1 binding sites have an open chromatin conformation. Nuclei from stimulated Th1 and Th2 cells were digested with DNase I; DNA was quantified using Q-PCR primers detecting the indicated regions. For each region, a representative dose response is shown; similar results were obtained by averaging three biological replicates digested with 8 μg/ml DNase I (data not shown). (A) Distal BRG1 binding regions are DHS in Th2 cells but not in Th1 cells. (B) Control regions lacking BRG1 binding are not DHS. (C) A control region with BRG1 binding in Th1 and Th2 cells is DHS in both. (D and E) Distal BRG1 binding sites possess enhancer-like activity. The indicated elements were placed immediately upstream (D) or 2.2 kb downstream (E) of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). (F) Enhancer-like activity is BRG1 dependent. The indicated elements were placed upstream of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. Cells were treated with BRG1 shRNA or a control, as indicated. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). (G) Distal BRG1 binding sites lack enhancer-like activity in a nonepisomal vector. The indicated elements were placed upstream of the SV40 promoter in the pGL3 promoter vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with (black bars) and without (white bars) stimulation. The horizontal line at 1 on the y axis indicates the value obtained with the promoter alone. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values (also indicated as a horizontal line). These same elements exhibited increased expression using episomal reporters (D and E). None of the five tested regions were positive for enhancer-like activity in this assay. (H) Distal regions without BRG1 binding in Th2 cells lack enhancer-like activity. The indicated elements were placed upstream of the SV40 promoter in the pRep4-luc episomal vector and transfected into CEM cells (human lymphoblastoid T cell line), and the reporter was assayed with stimulation. The horizontal line at 1 on the y axis indicates the value obtained with the promoter alone. Averages and standard deviations of the results from two biological replicate experiments are shown; all values are shown relative to the promoter values. All four tested regions lacking BRG1 binding were negative for enhancer-like activity in this assay.

    Techniques Used: Binding Assay, Activity Assay, Polymerase Chain Reaction, Plasmid Preparation, Transfection, shRNA, Expressing

    9) Product Images from "Transcriptional regulatory logic of the diurnal cycle in the mouse liver"

    Article Title: Transcriptional regulatory logic of the diurnal cycle in the mouse liver

    Journal: bioRxiv

    doi: 10.1101/077818

    Characteristics of DHSs. A. Distribution of distances between DHSs and nearest active TSSs. We observe a bimodal distribution, with a first mode corresponding to DHSs in promoter regions (centered on 100 bp from the TSS) and a second mode centered on 10 kb from TSSs. B. Repartition of DHSs within three classes depending on their distance from the nearest TSS: 47% are more than 10 kb from a TSS and are classified as distal, 28% are between 1 kb and 10 kb away and are classified as proximal, and DHSs located 1 kb or less from a TSS represent 24% of all sites. C.-D. Pol II, DHS and H3K27ac signals around TSSs and distal DHSs (averages over all sites). Profiles were normalized so that the maximum around the TSS is 100%. E. DNase I signals (all time points are merged in the ZT All track) near the Albumin gene. Footprint detected using the Wellington algorithm are shown below the detected DHS sites. The promoter region is enlarged at the bottom, showing that the wide footprint detected in our data corresponds to previously established transcription factor binding sites (the colored boxed indicate protein complexes previously identified in [ 47 ]). Many sensitive regions locate din the gene body do not display footprints, probably due to high transcription of Alb in the liver.
    Figure Legend Snippet: Characteristics of DHSs. A. Distribution of distances between DHSs and nearest active TSSs. We observe a bimodal distribution, with a first mode corresponding to DHSs in promoter regions (centered on 100 bp from the TSS) and a second mode centered on 10 kb from TSSs. B. Repartition of DHSs within three classes depending on their distance from the nearest TSS: 47% are more than 10 kb from a TSS and are classified as distal, 28% are between 1 kb and 10 kb away and are classified as proximal, and DHSs located 1 kb or less from a TSS represent 24% of all sites. C.-D. Pol II, DHS and H3K27ac signals around TSSs and distal DHSs (averages over all sites). Profiles were normalized so that the maximum around the TSS is 100%. E. DNase I signals (all time points are merged in the ZT All track) near the Albumin gene. Footprint detected using the Wellington algorithm are shown below the detected DHS sites. The promoter region is enlarged at the bottom, showing that the wide footprint detected in our data corresponds to previously established transcription factor binding sites (the colored boxed indicate protein complexes previously identified in [ 47 ]). Many sensitive regions locate din the gene body do not display footprints, probably due to high transcription of Alb in the liver.

    Techniques Used: Binding Assay

    Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6) at all time points. The analysis is identical to that in Figure 6A. The analysis for ZT6 in Bmal1 -/- mice is also shown.
    Figure Legend Snippet: Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6) at all time points. The analysis is identical to that in Figure 6A. The analysis for ZT6 in Bmal1 -/- mice is also shown.

    Techniques Used: Mouse Assay

    Genome-wide rhythms in DNase I signals are synchronous with Pol II transcription and histone acetylation. A. Number of DHSs with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds (p
    Figure Legend Snippet: Genome-wide rhythms in DNase I signals are synchronous with Pol II transcription and histone acetylation. A. Number of DHSs with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds (p

    Techniques Used: Genome Wide

    Location-dependent footprint characteristics of DHSs A. Visualization of DNase I signal (red) around the Rev-erb α promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1 binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (+/- 300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal.
    Figure Legend Snippet: Location-dependent footprint characteristics of DHSs A. Visualization of DNase I signal (red) around the Rev-erb α promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1 binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (+/- 300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal.

    Techniques Used: Binding Assay

    Measured DNase I-seq signals near the Dbp gene, compared with previously reporter DHSs in a reference study [ 30 ] (marked site_1 to site_7). [ 30 ] found seven hypersensitive sites while we detected six DHSs using our peak calling at compatible locations (black marks). Moreover, [ 30 ] reported high (sites 2, 4, 6, and 7, in green), or lower (sites 1, 3 and 5 in blue), amplitudes in rhythmic DNase I digestion efficiency, consistent with the DNase I-seq signals (visual inspection). Sites 2, 4, and 7 contain E-boxes that are binding sites for CLOCK and BMAL1. Locations of BMAL1 ChIP-seq signals (bottom track) [ 17 ] clearly overlaps strongest DNase I peaks.
    Figure Legend Snippet: Measured DNase I-seq signals near the Dbp gene, compared with previously reporter DHSs in a reference study [ 30 ] (marked site_1 to site_7). [ 30 ] found seven hypersensitive sites while we detected six DHSs using our peak calling at compatible locations (black marks). Moreover, [ 30 ] reported high (sites 2, 4, 6, and 7, in green), or lower (sites 1, 3 and 5 in blue), amplitudes in rhythmic DNase I digestion efficiency, consistent with the DNase I-seq signals (visual inspection). Sites 2, 4, and 7 contain E-boxes that are binding sites for CLOCK and BMAL1. Locations of BMAL1 ChIP-seq signals (bottom track) [ 17 ] clearly overlaps strongest DNase I peaks.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation

    Chromatin accessibility is generally similar in Bmal1 -/- and wild-type mice, but lower at BMAL1 bound sites in the former. A. The Rev-erb α (left) and Gsk3a (right) promoters, where DHSs are indicated with black ticks at the top. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by BMAL1:CLOCK in WT mice (BMAL1 ChIP-seq signal in blue) in the Rev-erb α promoter, but similar in WT and Bmal1 -/- mice at the Gsk3a promoter, not bound by BMAL1. The vertical scale is the same for all four DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. B. Comparison of DNase I signals at ZT6 in Bmal1 -/- versus WT mice. All DHSs overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown (n=1555). C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice. D.-E Same as B-C, but using overlap with USF1 ChIP-seq peaks [ 73 ] to select DHSs (n=1705).
    Figure Legend Snippet: Chromatin accessibility is generally similar in Bmal1 -/- and wild-type mice, but lower at BMAL1 bound sites in the former. A. The Rev-erb α (left) and Gsk3a (right) promoters, where DHSs are indicated with black ticks at the top. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by BMAL1:CLOCK in WT mice (BMAL1 ChIP-seq signal in blue) in the Rev-erb α promoter, but similar in WT and Bmal1 -/- mice at the Gsk3a promoter, not bound by BMAL1. The vertical scale is the same for all four DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. B. Comparison of DNase I signals at ZT6 in Bmal1 -/- versus WT mice. All DHSs overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown (n=1555). C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice. D.-E Same as B-C, but using overlap with USF1 ChIP-seq peaks [ 73 ] to select DHSs (n=1705).

    Techniques Used: Mouse Assay, Chromatin Immunoprecipitation

    DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, Pol II density, and H3K27ac enrichment at the Dbp locus. The DHS track shows the frequency nucleotide-resolved DNase I cuts, while H3K27ac and Pol II ChIP-seq signals are smoothed over 100 bp. All time points are overlaid. The center of each DHS-enriched region is indicated on top and corresponds exactly with previously identified DHSs ( Fig S1 ). B. Zoom-in around the DHS at the TSS of Dbp (position marked with a star also in A) reveals dynamics of DNase I cuts around the clock. Both DNase I and H3K27ac signals are maximal at ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription. C. Read counts (in log 2 units) for DNase 1 cuts (in windows of +/- 300 bp) centered on the Dbp TSS. Idem for Pol II and H3K27Ac ChIP-seq reads (in windows of +/- 1000 bp) centered on the same DHS and cosine fits show a common peak time around ZT10. Peak to trough amplitudes are about 16-fold for Pol II, and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest-TSS association according to annotation). Distances from the center of the plot indicate log 2 -amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. E.-H. Similar to A-D but for Npas2 , which has an opposite phase to Dbp , i.e. it peaks near ZT22.
    Figure Legend Snippet: DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, Pol II density, and H3K27ac enrichment at the Dbp locus. The DHS track shows the frequency nucleotide-resolved DNase I cuts, while H3K27ac and Pol II ChIP-seq signals are smoothed over 100 bp. All time points are overlaid. The center of each DHS-enriched region is indicated on top and corresponds exactly with previously identified DHSs ( Fig S1 ). B. Zoom-in around the DHS at the TSS of Dbp (position marked with a star also in A) reveals dynamics of DNase I cuts around the clock. Both DNase I and H3K27ac signals are maximal at ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription. C. Read counts (in log 2 units) for DNase 1 cuts (in windows of +/- 300 bp) centered on the Dbp TSS. Idem for Pol II and H3K27Ac ChIP-seq reads (in windows of +/- 1000 bp) centered on the same DHS and cosine fits show a common peak time around ZT10. Peak to trough amplitudes are about 16-fold for Pol II, and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest-TSS association according to annotation). Distances from the center of the plot indicate log 2 -amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. E.-H. Similar to A-D but for Npas2 , which has an opposite phase to Dbp , i.e. it peaks near ZT22.

    Techniques Used: Chromatin Immunoprecipitation, Activation Assay

    BMAL1 footprints indicate temporally changing protein-DNA complexes, consistent with binding of a hetero-tetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n=249 E1-E2 sp6 motifs overlapping a BMAL1 ChIP-seq peak, and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y-axis, green) of the protected region in WT and in Bmal1 -/- , for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y-axis). C. Two views of the 3D computational model of the CLOCK:BMAL1 hetero-tetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red.
    Figure Legend Snippet: BMAL1 footprints indicate temporally changing protein-DNA complexes, consistent with binding of a hetero-tetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n=249 E1-E2 sp6 motifs overlapping a BMAL1 ChIP-seq peak, and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y-axis, green) of the protected region in WT and in Bmal1 -/- , for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y-axis). C. Two views of the 3D computational model of the CLOCK:BMAL1 hetero-tetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation

    10) Product Images from "Role of the Promoter in Maintaining Transcriptionally Active Chromatin Structure and DNA Methylation Patterns In Vivo"

    Article Title: Role of the Promoter in Maintaining Transcriptionally Active Chromatin Structure and DNA Methylation Patterns In Vivo

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.23.12.4150-4161.2003

    Analysis of DNase I hypersensitivity. HT-1080 (male human fibrosarcoma) cells and Δ3B (HT-1080 cells carrying the promoter mutation) cells were treated with 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 μg of DNase I/ml. Southern blot analysis was performed on DNA digested with Eco RI and was hybridized to the HPRT promoter probe HPRT A. “HS site” indicates the positions of HPRT -hypersensitive sites; “globin” indicates the hybridization band detected by the control human β-globin probe.
    Figure Legend Snippet: Analysis of DNase I hypersensitivity. HT-1080 (male human fibrosarcoma) cells and Δ3B (HT-1080 cells carrying the promoter mutation) cells were treated with 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 μg of DNase I/ml. Southern blot analysis was performed on DNA digested with Eco RI and was hybridized to the HPRT promoter probe HPRT A. “HS site” indicates the positions of HPRT -hypersensitive sites; “globin” indicates the hybridization band detected by the control human β-globin probe.

    Techniques Used: Mutagenesis, Southern Blot, Hybridization

    Physical map of the human  HPRT  gene. The thick horizontal line represents the  HPRT  gene. Open horizontal boxes represent exons, and “ATG” indicates the translation initiation site. The bent arrow represents the major transcription initiation sites, and a putative initiator element is shaded. The gray box indicates the position of probe “HPRT A.” The bracket above the line indicates the position of the 5′ flanking DNase I-hypersensitive site. The positions of CpG-dinucleotides within the gene are shown as vertical lines below the gene map. Numbers indicate the position of CpGs relative to the translation initiation site. The horizontal bracket below the line indicates the region deleted in Δ2B and Δ3B cells.
    Figure Legend Snippet: Physical map of the human HPRT gene. The thick horizontal line represents the HPRT gene. Open horizontal boxes represent exons, and “ATG” indicates the translation initiation site. The bent arrow represents the major transcription initiation sites, and a putative initiator element is shaded. The gray box indicates the position of probe “HPRT A.” The bracket above the line indicates the position of the 5′ flanking DNase I-hypersensitive site. The positions of CpG-dinucleotides within the gene are shown as vertical lines below the gene map. Numbers indicate the position of CpGs relative to the translation initiation site. The horizontal bracket below the line indicates the region deleted in Δ2B and Δ3B cells.

    Techniques Used:

    11) Product Images from "Nucleosomes Are Translationally Positioned on the Active Allele and Rotationally Positioned on the Inactive Allele of the HPRT Promoter"

    Article Title: Nucleosomes Are Translationally Positioned on the Active Allele and Rotationally Positioned on the Inactive Allele of the HPRT Promoter

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.21.22.7682-7695.2001

    Summary of the nucleosomal organization of the active and inactive HPRT ) (vertical rectangles, their binding sites); bent arrow, position of the two major transcription initiation sites on the HPRT promoter; white box, first exon of the HPRT gene; ATG, position of the translation initiation site; thick vertical arrows, approximate positions and relative intensities of the major MNase cleavage sites in the HPRT promoter; clusters of thin triangular dashed arrows and barbed arrows, positions of the high-resolution DNase I cleavage ladders suggestive of rotationally positioned nucleosomes on the active and inactive HPRT promoters, respectively, in permeabilized cells (the slightly longer arrows on the lower strand in the inactive allele indicate that this ladder was unusually prominent); hatched bars, approximate locations of the DNase I-hypersensitive sites on the active HPRT promoter in permeabilized cells; All position numbers are relative to the translation initiation site.
    Figure Legend Snippet: Summary of the nucleosomal organization of the active and inactive HPRT ) (vertical rectangles, their binding sites); bent arrow, position of the two major transcription initiation sites on the HPRT promoter; white box, first exon of the HPRT gene; ATG, position of the translation initiation site; thick vertical arrows, approximate positions and relative intensities of the major MNase cleavage sites in the HPRT promoter; clusters of thin triangular dashed arrows and barbed arrows, positions of the high-resolution DNase I cleavage ladders suggestive of rotationally positioned nucleosomes on the active and inactive HPRT promoters, respectively, in permeabilized cells (the slightly longer arrows on the lower strand in the inactive allele indicate that this ladder was unusually prominent); hatched bars, approximate locations of the DNase I-hypersensitive sites on the active HPRT promoter in permeabilized cells; All position numbers are relative to the translation initiation site.

    Techniques Used: Binding Assay

    Locations of probes and primers for analysis of the HPRT promoter region. Horizontal line bounded by Bcl I sites, 4.3-kb Bcl I fragment containing the HPRT promoter; gray box, potential AP-2 site; five black boxes, cluster of GC boxes in the HPRT promoter; white box, first exon of the HPRT gene including the region of multiple transcription initiation sites in the promoter; ATG, translation initiation site; Bam HI, position of a reference Bam HI site in the first intron 100 bp downstream of the translation initiation site; hatched box, position of the 400-bp hybridization probe used to map DNase I and MNase cleavage sites in the HPRT promoter by indirect end labeling; black rectangles above and below the line, positions of the LMPCR primer sets used to map the high-resolution DNase I cleavage pattern of the HPRT minimal promoter; arrows extending from the black boxes, strand and region analyzed with each primer set.
    Figure Legend Snippet: Locations of probes and primers for analysis of the HPRT promoter region. Horizontal line bounded by Bcl I sites, 4.3-kb Bcl I fragment containing the HPRT promoter; gray box, potential AP-2 site; five black boxes, cluster of GC boxes in the HPRT promoter; white box, first exon of the HPRT gene including the region of multiple transcription initiation sites in the promoter; ATG, translation initiation site; Bam HI, position of a reference Bam HI site in the first intron 100 bp downstream of the translation initiation site; hatched box, position of the 400-bp hybridization probe used to map DNase I and MNase cleavage sites in the HPRT promoter by indirect end labeling; black rectangles above and below the line, positions of the LMPCR primer sets used to map the high-resolution DNase I cleavage pattern of the HPRT minimal promoter; arrows extending from the black boxes, strand and region analyzed with each primer set.

    Techniques Used: Hybridization, End Labeling

    DNase I in vivo footprint analysis of the human HPRT promoter. Active, samples from cells containing an active HPRT gene on the active human X chromosome; inactive, samples from cells containing an inactive HPRT gene on the inactive human X chromosome; DNA , naked DNA treated with DNase I; cells, DNA from permeabilized cells treated with DNase I; GC boxes, position of a DNase I in vivo footprint over the five GC boxes in the human HPRT promoter; AP-2, position of a DNase I in vivo footprint over a putative consensus AP-2 site in the human HPRT promoter. All position numbers (left and right) are relative to the translation initiation site of the HPRT gene. (A) DNase I in vivo footprint analysis of the upper strand of the HPRT promoter using LMPCR primer set E. Ladder of arrows, apparent 10-bp ladder of DNase I cleavages in permeabilized cells consistent with rotationally positioned nucleosomes on the inactive HPRT promoter. (B) DNase I in vivo footprinting analysis of the lower strand of the HPRT promoter using LMPCR primer set A. All designations and symbols are as described above. This analysis identifies footprints over both a cluster of five GC boxes and a putative AP-2 site in the active HPRT promoter. (C) DNase I in vivo footprinting analysis of the upper strand using LMPCR primer set C. All designations and symbols are as described above. This analysis identifies a DNase in vivo footprint over a putative AP-2 site on the active HPRT promoter.
    Figure Legend Snippet: DNase I in vivo footprint analysis of the human HPRT promoter. Active, samples from cells containing an active HPRT gene on the active human X chromosome; inactive, samples from cells containing an inactive HPRT gene on the inactive human X chromosome; DNA , naked DNA treated with DNase I; cells, DNA from permeabilized cells treated with DNase I; GC boxes, position of a DNase I in vivo footprint over the five GC boxes in the human HPRT promoter; AP-2, position of a DNase I in vivo footprint over a putative consensus AP-2 site in the human HPRT promoter. All position numbers (left and right) are relative to the translation initiation site of the HPRT gene. (A) DNase I in vivo footprint analysis of the upper strand of the HPRT promoter using LMPCR primer set E. Ladder of arrows, apparent 10-bp ladder of DNase I cleavages in permeabilized cells consistent with rotationally positioned nucleosomes on the inactive HPRT promoter. (B) DNase I in vivo footprinting analysis of the lower strand of the HPRT promoter using LMPCR primer set A. All designations and symbols are as described above. This analysis identifies footprints over both a cluster of five GC boxes and a putative AP-2 site in the active HPRT promoter. (C) DNase I in vivo footprinting analysis of the upper strand using LMPCR primer set C. All designations and symbols are as described above. This analysis identifies a DNase in vivo footprint over a putative AP-2 site on the active HPRT promoter.

    Techniques Used: In Vivo, Footprinting

    Summary of the 10-base DNase I cleavage ladders of chromatin from the active and inactive HPRT promoters. Boldface letters, protein-coding region of the first exon; lowercase letters, nucleotides within the first intron; partial ovals, approximate positions of the translationally positioned nucleosomes on the active HPRT promoter as determined by MNase cleavage; open boxes, positions of transcription factor (TF) binding sites. From top to bottom, left to right, the TF binding sites are a putative AP-1 site (−271 to −264), five GC boxes (centered at −213, −201, −187, −177, and −166), and a putative initiator element (−94 to −86). Bent arrows, positions of the two major transcription initiation sites identified by Kim et al. (16); line between the nucleotide sequence of the upper and lower strands, region of multiple transcription initiation sites described by Patel et al. (32); black triangles above the sequence, positions of DNase I cleavage sites on the upper strand comprising the 10-bp ladder suggestive of rotationally positioned nucleosomes in the inactive promoter; gray triangles below the sequence, positions of DNase I cleavages on the lower strand comprising the 10-bp ladder suggestive of rotationally positioned nucleosomes in the inactive promoter; white triangles, positions of DNase I cleavages on the lower strand making up the 10-bp ladder, suggestive of rotational positioning of a nucleosome on the active promoter region in permeabilized cells; vertical ovals, positions of three CpG dinucleotides whose methylation is strongly correlated with transcriptional repression of the HPRT ).
    Figure Legend Snippet: Summary of the 10-base DNase I cleavage ladders of chromatin from the active and inactive HPRT promoters. Boldface letters, protein-coding region of the first exon; lowercase letters, nucleotides within the first intron; partial ovals, approximate positions of the translationally positioned nucleosomes on the active HPRT promoter as determined by MNase cleavage; open boxes, positions of transcription factor (TF) binding sites. From top to bottom, left to right, the TF binding sites are a putative AP-1 site (−271 to −264), five GC boxes (centered at −213, −201, −187, −177, and −166), and a putative initiator element (−94 to −86). Bent arrows, positions of the two major transcription initiation sites identified by Kim et al. (16); line between the nucleotide sequence of the upper and lower strands, region of multiple transcription initiation sites described by Patel et al. (32); black triangles above the sequence, positions of DNase I cleavage sites on the upper strand comprising the 10-bp ladder suggestive of rotationally positioned nucleosomes in the inactive promoter; gray triangles below the sequence, positions of DNase I cleavages on the lower strand comprising the 10-bp ladder suggestive of rotationally positioned nucleosomes in the inactive promoter; white triangles, positions of DNase I cleavages on the lower strand making up the 10-bp ladder, suggestive of rotational positioning of a nucleosome on the active promoter region in permeabilized cells; vertical ovals, positions of three CpG dinucleotides whose methylation is strongly correlated with transcriptional repression of the HPRT ).

    Techniques Used: Binding Assay, Sequencing, Methylation

    12) Product Images from "Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity"

    Article Title: Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity

    Journal: Infection and Immunity

    doi: 10.1128/IAI.00545-15

    Reduced extracellular-trap (NET) formation in Hs2st-deficient neutrophils. (A) Human neutrophils were treated with 25 nM PMA for 3 h to allow NET formation, treated with heparan lyase III (5 mU/ml), fixed, and stained with mouse anti-stub heparan sulfate MAb, rabbit anti-myeloperoxidase PAb, and DAPI, followed by appropriate fluorochrome-conjugated secondary antibodies. (B) Human neutrophils were treated with 25 nM PMA for 3 h to induce NET formation and then treated with DNase I (10 U/ml) or heparan lyase I and III (5 mU/ml) for 30 min at 37°C, followed by incubation with GBS for 30 min. Surviving GBS were enumerated by serial plating. Differences between groups were calculated by unpaired t test. **, P
    Figure Legend Snippet: Reduced extracellular-trap (NET) formation in Hs2st-deficient neutrophils. (A) Human neutrophils were treated with 25 nM PMA for 3 h to allow NET formation, treated with heparan lyase III (5 mU/ml), fixed, and stained with mouse anti-stub heparan sulfate MAb, rabbit anti-myeloperoxidase PAb, and DAPI, followed by appropriate fluorochrome-conjugated secondary antibodies. (B) Human neutrophils were treated with 25 nM PMA for 3 h to induce NET formation and then treated with DNase I (10 U/ml) or heparan lyase I and III (5 mU/ml) for 30 min at 37°C, followed by incubation with GBS for 30 min. Surviving GBS were enumerated by serial plating. Differences between groups were calculated by unpaired t test. **, P

    Techniques Used: Staining, Incubation

    13) Product Images from "Controller protein of restriction–modification system Kpn2I affects transcription of its gene by acting as a transcription elongation roadblock"

    Article Title: Controller protein of restriction–modification system Kpn2I affects transcription of its gene by acting as a transcription elongation roadblock

    Journal: Nucleic Acids Research

    doi: 10.1093/nar/gky880

    Genetic organization of restriction–modification system Kpn2I. In the middle of the figure, the Kpn2I genes are schematically shown by colored arrows, with arrow direction matching the direction of transcription. The DNA sequence upstream of the kpn 2I R gene (both strands) is expanded at the top. The initiating codon of the kpn 2I. R reading frame is indicated; the transcription start points of kpn 2I .R promoters are shown by arrows, likely -10 and -35 promoter elements are underlined, nucleotides matching promoter element consensus are shown in bold. The sequence of the intergenic region between and the beginnings of oppositely transcribed kpn 2I. M and kpn 2I .C genes is expanded below. Initiating codons of both ORFs, transcription start points, and promoter consensus elements are indicated. Sequences downstream of initiating codons are colored to match the coloring scheme of the genes as shown in the middle of the figure (dark blue for kpn 2I .R , red for kpn 2I .M , dark green for kpn 2I .C ). Arrows indicating transcription start points are also colored to match the same coloring scheme. Arrows of darker shades indicate stronger promoters. The binding site of C.Kpn2I (as determined by DNase I and Exo III footprinting) is shown by an orange-colored horizontal line and marked ‘C box’). The likely UP element of kpn 2I .M is marked.
    Figure Legend Snippet: Genetic organization of restriction–modification system Kpn2I. In the middle of the figure, the Kpn2I genes are schematically shown by colored arrows, with arrow direction matching the direction of transcription. The DNA sequence upstream of the kpn 2I R gene (both strands) is expanded at the top. The initiating codon of the kpn 2I. R reading frame is indicated; the transcription start points of kpn 2I .R promoters are shown by arrows, likely -10 and -35 promoter elements are underlined, nucleotides matching promoter element consensus are shown in bold. The sequence of the intergenic region between and the beginnings of oppositely transcribed kpn 2I. M and kpn 2I .C genes is expanded below. Initiating codons of both ORFs, transcription start points, and promoter consensus elements are indicated. Sequences downstream of initiating codons are colored to match the coloring scheme of the genes as shown in the middle of the figure (dark blue for kpn 2I .R , red for kpn 2I .M , dark green for kpn 2I .C ). Arrows indicating transcription start points are also colored to match the same coloring scheme. Arrows of darker shades indicate stronger promoters. The binding site of C.Kpn2I (as determined by DNase I and Exo III footprinting) is shown by an orange-colored horizontal line and marked ‘C box’). The likely UP element of kpn 2I .M is marked.

    Techniques Used: Modification, Sequencing, Binding Assay, Footprinting

    In vitro transcription and RNAP promoter complex formation in the presence of C.Kpn2I. ( A ). Results of multiple-round transcription by σ 70 RNAP holoenzyme with wild-type (‘wt’) α subunit or with α lacking the CTD domain (‘-αCTD’) from a DNA fragment containing the intergenic region between kpn 2I .M and kpn 2I .C in the presence or in the absence of added C.Kpn2I. ( B ) The same DNA fragment was combined with σ 70 RNAP holoenzyme, C.Kpn2I, or both and subjected to DNase I footprinting. ( C ) As in B but showing the results of KMnO 4 probing of complexes formed by σ 70 RNAP holoenzymes with wild-type α or α lacking the CTD. ( D ) Results of multiple-round transcription in the presence or in the absence of C.Kpn2I by RNAP holoenzymes containing wild-type σ 70 or σ 1–565 lacking the region 4 domain. In addition to transcription from the kpn 2I .M promoter, results of transcription from strong -10/-35 class promoter T7 A1 and extended –10 class gal P1 promoter are shown.
    Figure Legend Snippet: In vitro transcription and RNAP promoter complex formation in the presence of C.Kpn2I. ( A ). Results of multiple-round transcription by σ 70 RNAP holoenzyme with wild-type (‘wt’) α subunit or with α lacking the CTD domain (‘-αCTD’) from a DNA fragment containing the intergenic region between kpn 2I .M and kpn 2I .C in the presence or in the absence of added C.Kpn2I. ( B ) The same DNA fragment was combined with σ 70 RNAP holoenzyme, C.Kpn2I, or both and subjected to DNase I footprinting. ( C ) As in B but showing the results of KMnO 4 probing of complexes formed by σ 70 RNAP holoenzymes with wild-type α or α lacking the CTD. ( D ) Results of multiple-round transcription in the presence or in the absence of C.Kpn2I by RNAP holoenzymes containing wild-type σ 70 or σ 1–565 lacking the region 4 domain. In addition to transcription from the kpn 2I .M promoter, results of transcription from strong -10/-35 class promoter T7 A1 and extended –10 class gal P1 promoter are shown.

    Techniques Used: In Vitro, Footprinting

    Mapping of the C.Kpn2I binding site. DNase I ( A ) and Exo III ( B ) footprinting of C.Kpn2I complexes formed on a DNA fragment separating kpn 2I .M and kpn 2I .C . Results obtained with DNA fragment labeled at either top or bottom strands (see Figure 1 ) in the presence or in the absence of C.Kpn2I are shown. Areas protected by C.Kpn2I from DNase I digestion are indicated by blue-colored brackets at both sides of the gel shown in panel A (also shown by orange line at the bottom of Figure 1 ). The positions of Exo III stalling points during DNA digestion in B are shown by horizontal arrows. ( C ) Summary of footprinting results. The positions of Exo III stalls and areas of DNA protection on both strands are shown by vertical arrows and horizontal blue lines, respectively. The –35 element of the kpn 2I .M promoter is underlined. The initiating TTG (Leu 1 ) codon of kpn 2I .C and the Met 9 ATG are indicated (see text for det ails). The left- and right half sites fragments used in EMSA experiments are indicated. ( D ) A double-stranded radioactively-labeled Kpn2I DNA fragment shown in C (‘full C-box’) or shorter fragments corresponding to its left- and right-hand side halves were combined with increasing amounts of C.Kpn2I and reaction products were resolved by native PAGE. ‘F’ indicates free DNA, ‘D’—a complex likely bound to C.Kpn2I dimer, ‘T’—a complex bound to C.Kpn2I tetramer.
    Figure Legend Snippet: Mapping of the C.Kpn2I binding site. DNase I ( A ) and Exo III ( B ) footprinting of C.Kpn2I complexes formed on a DNA fragment separating kpn 2I .M and kpn 2I .C . Results obtained with DNA fragment labeled at either top or bottom strands (see Figure 1 ) in the presence or in the absence of C.Kpn2I are shown. Areas protected by C.Kpn2I from DNase I digestion are indicated by blue-colored brackets at both sides of the gel shown in panel A (also shown by orange line at the bottom of Figure 1 ). The positions of Exo III stalling points during DNA digestion in B are shown by horizontal arrows. ( C ) Summary of footprinting results. The positions of Exo III stalls and areas of DNA protection on both strands are shown by vertical arrows and horizontal blue lines, respectively. The –35 element of the kpn 2I .M promoter is underlined. The initiating TTG (Leu 1 ) codon of kpn 2I .C and the Met 9 ATG are indicated (see text for det ails). The left- and right half sites fragments used in EMSA experiments are indicated. ( D ) A double-stranded radioactively-labeled Kpn2I DNA fragment shown in C (‘full C-box’) or shorter fragments corresponding to its left- and right-hand side halves were combined with increasing amounts of C.Kpn2I and reaction products were resolved by native PAGE. ‘F’ indicates free DNA, ‘D’—a complex likely bound to C.Kpn2I dimer, ‘T’—a complex bound to C.Kpn2I tetramer.

    Techniques Used: Binding Assay, Footprinting, Labeling, Clear Native PAGE

    14) Product Images from "Further Unraveling the Regulatory Twist by Elucidating Metabolic Coinducer-Mediated CbbR-cbbI Promoter Interactions in Rhodopseudomonas palustris CGA010"

    Article Title: Further Unraveling the Regulatory Twist by Elucidating Metabolic Coinducer-Mediated CbbR-cbbI Promoter Interactions in Rhodopseudomonas palustris CGA010

    Journal: Journal of Bacteriology

    doi: 10.1128/JB.06418-11

    Summary of DNase I protection results in the absence (A) or presence (B to E) of coinducers, including (B) RuBP, (C) NADPH, (D) ATP, and (E) FBP, each at 500 μM. Results are compared to a BSA control. Putative CbbR binding sites are indicated
    Figure Legend Snippet: Summary of DNase I protection results in the absence (A) or presence (B to E) of coinducers, including (B) RuBP, (C) NADPH, (D) ATP, and (E) FBP, each at 500 μM. Results are compared to a BSA control. Putative CbbR binding sites are indicated

    Techniques Used: Binding Assay

    DNase I footprinting of the CbbR binding sites on the cbbLS region in the presence of coinducer. The DNase I-digested reactions were prepared and analyzed by capillary electrophoresis with a 3730 DNA analyzer (Applied Biosystems). The differences in the
    Figure Legend Snippet: DNase I footprinting of the CbbR binding sites on the cbbLS region in the presence of coinducer. The DNase I-digested reactions were prepared and analyzed by capillary electrophoresis with a 3730 DNA analyzer (Applied Biosystems). The differences in the

    Techniques Used: Footprinting, Binding Assay, Electrophoresis

    15) Product Images from "STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells"

    Article Title: STAT3, STAT4, NFATc1, and CTCF regulate PD-1 through multiple novel regulatory regions in murine T cells

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    doi: 10.4049/jimmunol.1302750

    The Pdcd1 locus contains multiple inducible DNase I hypersensitive sites
    Figure Legend Snippet: The Pdcd1 locus contains multiple inducible DNase I hypersensitive sites

    Techniques Used:

    16) Product Images from "Association of Herpes Simplex Virus Type 1 ICP8 and ICP27 Proteins with Cellular RNA Polymerase II Holoenzyme"

    Article Title: Association of Herpes Simplex Virus Type 1 ICP8 and ICP27 Proteins with Cellular RNA Polymerase II Holoenzyme

    Journal: Journal of Virology

    doi: 10.1128/JVI.76.12.5893-5904.2002

    Role of nucleic acids in association of HSV proteins with the Pol II holoenzyme. HEp-2 cells were infected with wt HSV-1 or mock-infected and harvested at 8 h p.i. (A) Cell lysates were untreated or treated with an various amounts of RNases or with DNase I and then were subjected to immunoprecipitation (IP) with rabbit anti-Pol II antibody C21. Proteins in cell lysates and the Pol II immunoprecipitates were resolved by SDS-PAGE and detected by Western blotting with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:13 for lanes 6, 8, 10, 12, and 14 and 1:26 for lanes 7, 9, 11, 13, and 15. 1x, cell lysate was treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min; 3x, cell lysate was treated with 75 U of RNase A/ml and 3,000 U of RNase T 1 /ml at 30°C for 30 min; DNase, cell lysate was treated with 10 μg of DNase I/ml. No, no nuclease during incubation. (B) Cell lysates were untreated or treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min. Immunoprecipitations were performed with monoclonal anti-ICP27 antibody H1113 on RNase-treated and untreated cell lysates in the absence or presence of ethidium bromide. Proteins in cell lysates and immunoprecipitates were resolved by SDS-PAGE and detected with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:40. EtBr, immunoprecipitation was done on untreated HSV-infected cell lysate in the presence of 50 μg of ethidium bromide/ml.
    Figure Legend Snippet: Role of nucleic acids in association of HSV proteins with the Pol II holoenzyme. HEp-2 cells were infected with wt HSV-1 or mock-infected and harvested at 8 h p.i. (A) Cell lysates were untreated or treated with an various amounts of RNases or with DNase I and then were subjected to immunoprecipitation (IP) with rabbit anti-Pol II antibody C21. Proteins in cell lysates and the Pol II immunoprecipitates were resolved by SDS-PAGE and detected by Western blotting with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:13 for lanes 6, 8, 10, 12, and 14 and 1:26 for lanes 7, 9, 11, 13, and 15. 1x, cell lysate was treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min; 3x, cell lysate was treated with 75 U of RNase A/ml and 3,000 U of RNase T 1 /ml at 30°C for 30 min; DNase, cell lysate was treated with 10 μg of DNase I/ml. No, no nuclease during incubation. (B) Cell lysates were untreated or treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min. Immunoprecipitations were performed with monoclonal anti-ICP27 antibody H1113 on RNase-treated and untreated cell lysates in the absence or presence of ethidium bromide. Proteins in cell lysates and immunoprecipitates were resolved by SDS-PAGE and detected with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:40. EtBr, immunoprecipitation was done on untreated HSV-infected cell lysate in the presence of 50 μg of ethidium bromide/ml.

    Techniques Used: Infection, Immunoprecipitation, SDS Page, Western Blot, Incubation

    17) Product Images from "Association of Herpes Simplex Virus Type 1 ICP8 and ICP27 Proteins with Cellular RNA Polymerase II Holoenzyme"

    Article Title: Association of Herpes Simplex Virus Type 1 ICP8 and ICP27 Proteins with Cellular RNA Polymerase II Holoenzyme

    Journal: Journal of Virology

    doi: 10.1128/JVI.76.12.5893-5904.2002

    Role of nucleic acids in association of HSV proteins with the Pol II holoenzyme. HEp-2 cells were infected with wt HSV-1 or mock-infected and harvested at 8 h p.i. (A) Cell lysates were untreated or treated with an various amounts of RNases or with DNase I and then were subjected to immunoprecipitation (IP) with rabbit anti-Pol II antibody C21. Proteins in cell lysates and the Pol II immunoprecipitates were resolved by SDS-PAGE and detected by Western blotting with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:13 for lanes 6, 8, 10, 12, and 14 and 1:26 for lanes 7, 9, 11, 13, and 15. 1x, cell lysate was treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min; 3x, cell lysate was treated with 75 U of RNase A/ml and 3,000 U of RNase T 1 /ml at 30°C for 30 min; DNase, cell lysate was treated with 10 μg of DNase I/ml. No, no nuclease during incubation. (B) Cell lysates were untreated or treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min. Immunoprecipitations were performed with monoclonal anti-ICP27 antibody H1113 on RNase-treated and untreated cell lysates in the absence or presence of ethidium bromide. Proteins in cell lysates and immunoprecipitates were resolved by SDS-PAGE and detected with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:40. EtBr, immunoprecipitation was done on untreated HSV-infected cell lysate in the presence of 50 μg of ethidium bromide/ml.
    Figure Legend Snippet: Role of nucleic acids in association of HSV proteins with the Pol II holoenzyme. HEp-2 cells were infected with wt HSV-1 or mock-infected and harvested at 8 h p.i. (A) Cell lysates were untreated or treated with an various amounts of RNases or with DNase I and then were subjected to immunoprecipitation (IP) with rabbit anti-Pol II antibody C21. Proteins in cell lysates and the Pol II immunoprecipitates were resolved by SDS-PAGE and detected by Western blotting with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:13 for lanes 6, 8, 10, 12, and 14 and 1:26 for lanes 7, 9, 11, 13, and 15. 1x, cell lysate was treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min; 3x, cell lysate was treated with 75 U of RNase A/ml and 3,000 U of RNase T 1 /ml at 30°C for 30 min; DNase, cell lysate was treated with 10 μg of DNase I/ml. No, no nuclease during incubation. (B) Cell lysates were untreated or treated with 25 U of RNase A/ml and 1,000 U of RNase T 1 /ml at 30°C for 30 min. Immunoprecipitations were performed with monoclonal anti-ICP27 antibody H1113 on RNase-treated and untreated cell lysates in the absence or presence of ethidium bromide. Proteins in cell lysates and immunoprecipitates were resolved by SDS-PAGE and detected with anti-Pol II antibody 8WG16 (1:1,000 dilution), anti-ICP8 antiserum 3-83 (1:1,000 dilution), and anti-ICP27 antibody H1113 (1:200 dilution). The ratio of cell lysate loaded on the gel to the amount of lysate used in immunoprecipitation was 1:40. EtBr, immunoprecipitation was done on untreated HSV-infected cell lysate in the presence of 50 μg of ethidium bromide/ml.

    Techniques Used: Infection, Immunoprecipitation, SDS Page, Western Blot, Incubation

    18) Product Images from "NET formation can occur independently of RIPK3 and MLKL signaling"

    Article Title: NET formation can occur independently of RIPK3 and MLKL signaling

    Journal: European Journal of Immunology

    doi: 10.1002/eji.201545615

    The formation of human NETs occurs independently of MLKL signaling . Human blood neutrophils were isolated from healthy donors by Ficoll‐Hypaque centrifugation. (A) Confocal microscopy. NET formation following short‐term stimulation (total 45 min) of human neutrophils with the indicated triggers in the presence and absence of 5 μM NSA. The number of NET‐forming neutrophils was determined by counting the DNA‐releasing cells in ten high power fields ( n = 5). Representative original data (right). Co‐localization of elastase (green) with released DNA (PI, red) is indicated by the yellow color. Bars, 10 μM. (B) Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen fluorescent dye ( n = 3). (C) Total ROS production by activated human neutrophils in the presence and absence of 5 μM NSA was measured by flow cytometry. During cell activation, cells were incubated with 1 μM DHR123 ( n = 3). (D) Bacterial killing by colony forming unit (cfu) assay. Human neutrophils exert antibacterial activity against E. coli that can be partially blocked by 100 U/mL DNase I both in the presence and absence of 5 μM NSA ( n = 3). (E) Viability of Jurkat cells was analyzed by ethidium bromide exclusion assay. In parallel experiments, 5 μM NSA blocked cell death induced by 20 ng/mL TNF‐α plus 100 nM Smac mimetic AT‐406 (cIAP1/2 selective IAP‐antagonist) in caspase‐8 deficient and 20 μM zVAD‐FMK–treated Jurkat cells ( n = 3), demonstrating that the inhibitor was pharmacologically active. All data are shown as mean ± SEM of the indicated number of independent experiments. * p
    Figure Legend Snippet: The formation of human NETs occurs independently of MLKL signaling . Human blood neutrophils were isolated from healthy donors by Ficoll‐Hypaque centrifugation. (A) Confocal microscopy. NET formation following short‐term stimulation (total 45 min) of human neutrophils with the indicated triggers in the presence and absence of 5 μM NSA. The number of NET‐forming neutrophils was determined by counting the DNA‐releasing cells in ten high power fields ( n = 5). Representative original data (right). Co‐localization of elastase (green) with released DNA (PI, red) is indicated by the yellow color. Bars, 10 μM. (B) Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen fluorescent dye ( n = 3). (C) Total ROS production by activated human neutrophils in the presence and absence of 5 μM NSA was measured by flow cytometry. During cell activation, cells were incubated with 1 μM DHR123 ( n = 3). (D) Bacterial killing by colony forming unit (cfu) assay. Human neutrophils exert antibacterial activity against E. coli that can be partially blocked by 100 U/mL DNase I both in the presence and absence of 5 μM NSA ( n = 3). (E) Viability of Jurkat cells was analyzed by ethidium bromide exclusion assay. In parallel experiments, 5 μM NSA blocked cell death induced by 20 ng/mL TNF‐α plus 100 nM Smac mimetic AT‐406 (cIAP1/2 selective IAP‐antagonist) in caspase‐8 deficient and 20 μM zVAD‐FMK–treated Jurkat cells ( n = 3), demonstrating that the inhibitor was pharmacologically active. All data are shown as mean ± SEM of the indicated number of independent experiments. * p

    Techniques Used: Isolation, Centrifugation, Confocal Microscopy, Flow Cytometry, Cytometry, Activation Assay, Incubation, Colony-forming Unit Assay, Activity Assay, Exclusion Assay

    The formation of mouse NETs is independent of RIPK3 . Mature mouse neutrophils were isolated from bone marrow of wild‐type and  Ripk3 ‐deficient mice. (A) Immunoblotting. Bone marrow cells from wild‐type and  Ripk3 ‐deficient mice were analyzed for RIPK3 protein expression. Three mice per genotype are shown. (B) Quantification of NET‐forming neutrophils by confocal microscopy. NET formation following short‐term stimulation (total 45 min) of mouse neutrophils with the indicated triggers. The number of NET‐forming neutrophils was determined by counting the DNA‐releasing cells in ten high power fields (Supporting Information Fig. 1A and Supporting Information Movie 1). No statistical differences were observed between wild‐type and  Ripk3 ‐deficient cells ( n  = 3). (C) Representative microscopy. Co‐localization (arrows) of elastase (green) with released DNA (PI, red) assessed by confocal microscopy. Bars, 10 μM. (D) Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen fluorescent dye. A significant difference in dsDNA release was detected between control and activated cells, but not between wild‐type and  Ripk3 ‐deficient neutrophils ( n  = 3). (E) Total ROS activity assessed by DHR123 fluorescence and flow cytometry ( n  = 3). (F) Quantification of H 2 O 2  production upon activation of neutrophils was performed using luminescent ROS‐Glo that measures H 2 O 2  levels directly in cell culture. Again, ROS activity is increased in activated mouse neutrophils, but no statistical differences were observed between wild‐type and  Ripk3 ‐deficient cells ( n  = 3). (G) Bacterial killing by colony formation unit (cfu) assay ( n  = 3). Mouse neutrophils exert antibacterial activity against  E. coli  that can be partially blocked by 100 U/mL DNase I. All data are shown as mean ± SEM of the indicated number of independent experiments. * p
    Figure Legend Snippet: The formation of mouse NETs is independent of RIPK3 . Mature mouse neutrophils were isolated from bone marrow of wild‐type and Ripk3 ‐deficient mice. (A) Immunoblotting. Bone marrow cells from wild‐type and Ripk3 ‐deficient mice were analyzed for RIPK3 protein expression. Three mice per genotype are shown. (B) Quantification of NET‐forming neutrophils by confocal microscopy. NET formation following short‐term stimulation (total 45 min) of mouse neutrophils with the indicated triggers. The number of NET‐forming neutrophils was determined by counting the DNA‐releasing cells in ten high power fields (Supporting Information Fig. 1A and Supporting Information Movie 1). No statistical differences were observed between wild‐type and Ripk3 ‐deficient cells ( n = 3). (C) Representative microscopy. Co‐localization (arrows) of elastase (green) with released DNA (PI, red) assessed by confocal microscopy. Bars, 10 μM. (D) Quantification of dsDNA in supernatants of activated neutrophils using PicoGreen fluorescent dye. A significant difference in dsDNA release was detected between control and activated cells, but not between wild‐type and Ripk3 ‐deficient neutrophils ( n = 3). (E) Total ROS activity assessed by DHR123 fluorescence and flow cytometry ( n = 3). (F) Quantification of H 2 O 2 production upon activation of neutrophils was performed using luminescent ROS‐Glo that measures H 2 O 2 levels directly in cell culture. Again, ROS activity is increased in activated mouse neutrophils, but no statistical differences were observed between wild‐type and Ripk3 ‐deficient cells ( n = 3). (G) Bacterial killing by colony formation unit (cfu) assay ( n = 3). Mouse neutrophils exert antibacterial activity against E. coli that can be partially blocked by 100 U/mL DNase I. All data are shown as mean ± SEM of the indicated number of independent experiments. * p

    Techniques Used: Isolation, Mouse Assay, Expressing, Confocal Microscopy, Microscopy, Activity Assay, Fluorescence, Flow Cytometry, Cytometry, Activation Assay, Cell Culture, Colony-forming Unit Assay

    19) Product Images from "Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis"

    Article Title: Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis

    Journal: Microbes and infection / Institut Pasteur

    doi: 10.1016/j.micinf.2014.02.012

    NETs are required for larval killing by human neutrophils in vitro. A) Human macrophages (Mϕ) and neutrophils (PMN) cultured in vitro with 50 larvae (L3) for 48 h. The cultures were treated with 100 U/ml of DNase I to block NET formation and assessed
    Figure Legend Snippet: NETs are required for larval killing by human neutrophils in vitro. A) Human macrophages (Mϕ) and neutrophils (PMN) cultured in vitro with 50 larvae (L3) for 48 h. The cultures were treated with 100 U/ml of DNase I to block NET formation and assessed

    Techniques Used: In Vitro, Cell Culture, Blocking Assay

    20) Product Images from "A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group"

    Article Title: A cell-cell signaling peptide activates the PlcR virulence regulon in bacteria of the Bacillus cereus group

    Journal: The EMBO Journal

    doi: 10.1093/emboj/cdf450

    Fig. 8. ( A ) β-galactosidase activity of the B.thuringiensis 407 Cry – A ′ Z Δ papR mutant strain. The cells were grown at 37°C in LB medium and each peptide (OS5, OS5-I1, OS5-M1 and OS5-V1; all 0.5 µM) was added at t 1 (1 h after the onset of the stationary phase). The amino acid sequences of the peptides are as follows: OS5, LPFEF; OS5-I1, IPFEF; OS5-M1, MPFEF; OS5-V1, VPFEF. ( B ) DNase I footprinting analysis of PlcR binding to the plcA promoter region in the presence of various pentapeptides. Lane 1, G+A Maxam and Gilbert reaction; lane 2, no protein; lane 3, 1.2 µg of PlcR (35 pmol); lane 4, 1.2 µg of PlcR and of OS5 10 µg; lane 5, 1.2 µg of PlcR and 10 µg of OS5-I1; lane 6, 1.2 µg of PlcR and 10 µg of OS5-M1; lane 7, 1.2 µg of PlcR and 10 µg of OS5-V1. The region protected by PlcR is indicated by a bracket and corresponds to the PlcR box upstream from the plcA gene.
    Figure Legend Snippet: Fig. 8. ( A ) β-galactosidase activity of the B.thuringiensis 407 Cry – A ′ Z Δ papR mutant strain. The cells were grown at 37°C in LB medium and each peptide (OS5, OS5-I1, OS5-M1 and OS5-V1; all 0.5 µM) was added at t 1 (1 h after the onset of the stationary phase). The amino acid sequences of the peptides are as follows: OS5, LPFEF; OS5-I1, IPFEF; OS5-M1, MPFEF; OS5-V1, VPFEF. ( B ) DNase I footprinting analysis of PlcR binding to the plcA promoter region in the presence of various pentapeptides. Lane 1, G+A Maxam and Gilbert reaction; lane 2, no protein; lane 3, 1.2 µg of PlcR (35 pmol); lane 4, 1.2 µg of PlcR and of OS5 10 µg; lane 5, 1.2 µg of PlcR and 10 µg of OS5-I1; lane 6, 1.2 µg of PlcR and 10 µg of OS5-M1; lane 7, 1.2 µg of PlcR and 10 µg of OS5-V1. The region protected by PlcR is indicated by a bracket and corresponds to the PlcR box upstream from the plcA gene.

    Techniques Used: Activity Assay, Mutagenesis, Footprinting, Binding Assay

    Fig. 6. DNase I footprinting analysis of PlcR binding to the plcA promoter region. Radiolabeled fragments (50 000 c.p.m.) were incubated with various concentrations of PlcR and OS5. ( A ) Lane 1, G+A Maxam and Gilbert reaction; lane 2, no protein; lane 3, 0.1 µg of PlcR; lane 4, 10 µg of PlcR; lane 5, 20 µg of OS5; lane 6, 0.1 µg of PlcR and 10 µg of OS5; lane 7, 0.1 µg of PlcR and 20 µg of OS5; lane 8, 10 µg of PlcR and 10 µg of OS5; lane 9, 10 µg of PlcR and 20 µg of OS5. The region protected by PlcR is indicated by a bracket. ( B ) Lane 1, G+A Maxam and Gilbert reaction; lanes 2–8, 50 pmol of PlcR (1.7 µg) and OS5: lane 2, 1000 pmol (0.65 µg); lane 3, 500 pmol; lane 4, 150 pmol; lane 5, 70 pmol; lane 6, 35 pmol; lane 7, 10 pmol; lane 8, 5 pmol; lane 9, 50 pmol of PlcR; lane 10, neither protein nor peptide. ( C ) plcA promoter region. The DNase I-protected area is indicated by a bracket and the PlcR box is in bold. Positions are relative to the transcription start point. The –35 and –10 promoter regions, and the transcription start (+ 1) of the plcA ).
    Figure Legend Snippet: Fig. 6. DNase I footprinting analysis of PlcR binding to the plcA promoter region. Radiolabeled fragments (50 000 c.p.m.) were incubated with various concentrations of PlcR and OS5. ( A ) Lane 1, G+A Maxam and Gilbert reaction; lane 2, no protein; lane 3, 0.1 µg of PlcR; lane 4, 10 µg of PlcR; lane 5, 20 µg of OS5; lane 6, 0.1 µg of PlcR and 10 µg of OS5; lane 7, 0.1 µg of PlcR and 20 µg of OS5; lane 8, 10 µg of PlcR and 10 µg of OS5; lane 9, 10 µg of PlcR and 20 µg of OS5. The region protected by PlcR is indicated by a bracket. ( B ) Lane 1, G+A Maxam and Gilbert reaction; lanes 2–8, 50 pmol of PlcR (1.7 µg) and OS5: lane 2, 1000 pmol (0.65 µg); lane 3, 500 pmol; lane 4, 150 pmol; lane 5, 70 pmol; lane 6, 35 pmol; lane 7, 10 pmol; lane 8, 5 pmol; lane 9, 50 pmol of PlcR; lane 10, neither protein nor peptide. ( C ) plcA promoter region. The DNase I-protected area is indicated by a bracket and the PlcR box is in bold. Positions are relative to the transcription start point. The –35 and –10 promoter regions, and the transcription start (+ 1) of the plcA ).

    Techniques Used: Footprinting, Binding Assay, Incubation

    21) Product Images from "Epigenetic Control of Cell Cycle-Dependent Histone Gene Expression Is a Principal Component of the Abbreviated Pluripotent Cell Cycle"

    Article Title: Epigenetic Control of Cell Cycle-Dependent Histone Gene Expression Is a Principal Component of the Abbreviated Pluripotent Cell Cycle

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.00736-12

    Chromatin architecture of the human histone H4 gene in hES cells. (A) DNase I hypersensitivity at the human histone H4 gene ( HIST2H4 ). Nuclei were isolated from hES cells (lanes 4 to 6) and normal diploid fibroblasts (TIG-1 and IMR-90; lanes 7 to 9 and
    Figure Legend Snippet: Chromatin architecture of the human histone H4 gene in hES cells. (A) DNase I hypersensitivity at the human histone H4 gene ( HIST2H4 ). Nuclei were isolated from hES cells (lanes 4 to 6) and normal diploid fibroblasts (TIG-1 and IMR-90; lanes 7 to 9 and

    Techniques Used: Isolation

    22) Product Images from "Epigenetic Control of Cell Cycle-Dependent Histone Gene Expression Is a Principal Component of the Abbreviated Pluripotent Cell Cycle"

    Article Title: Epigenetic Control of Cell Cycle-Dependent Histone Gene Expression Is a Principal Component of the Abbreviated Pluripotent Cell Cycle

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.00736-12

    Chromatin architecture of the human histone H4 gene in hES cells. (A) DNase I hypersensitivity at the human histone H4 gene ( HIST2H4 ). Nuclei were isolated from hES cells (lanes 4 to 6) and normal diploid fibroblasts (TIG-1 and IMR-90; lanes 7 to 9 and
    Figure Legend Snippet: Chromatin architecture of the human histone H4 gene in hES cells. (A) DNase I hypersensitivity at the human histone H4 gene ( HIST2H4 ). Nuclei were isolated from hES cells (lanes 4 to 6) and normal diploid fibroblasts (TIG-1 and IMR-90; lanes 7 to 9 and

    Techniques Used: Isolation

    23) Product Images from "Interactions of NBU1 IntN1 and Orf2x Proteins with Attachment Site DNA"

    Article Title: Interactions of NBU1 IntN1 and Orf2x Proteins with Attachment Site DNA

    Journal: Journal of Bacteriology

    doi: 10.1128/JB.01011-13

    (A) DNase I footprint of IntN1 on the top strand of attL . Panel 1 shows a sequencing ladder generated using dideoxy sequencing reactions with the same 6-FAM-labeled primer used to make the footprinting substrate; green denotes adenine, blue denotes cytosine,
    Figure Legend Snippet: (A) DNase I footprint of IntN1 on the top strand of attL . Panel 1 shows a sequencing ladder generated using dideoxy sequencing reactions with the same 6-FAM-labeled primer used to make the footprinting substrate; green denotes adenine, blue denotes cytosine,

    Techniques Used: Sequencing, Generated, Labeling, Footprinting

    (A) DNase I footprint of Orf2x on the bottom strand of attL . Fluorescently labeled attL DNA was PCR amplified and used in footprinting experiments with Orf2x. The top panel shows a sequencing ladder generated using dideoxy sequencing reactions with the
    Figure Legend Snippet: (A) DNase I footprint of Orf2x on the bottom strand of attL . Fluorescently labeled attL DNA was PCR amplified and used in footprinting experiments with Orf2x. The top panel shows a sequencing ladder generated using dideoxy sequencing reactions with the

    Techniques Used: Labeling, Polymerase Chain Reaction, Amplification, Footprinting, Sequencing, Generated

    (A) Alignment of four core-type sites as determined by DNase I footprinting. The consensus sequence was derived by comparing each base between the four core-type sites. Y, T or C; N, any base. (B) Alignment of six arm-type sites as determined by DNase
    Figure Legend Snippet: (A) Alignment of four core-type sites as determined by DNase I footprinting. The consensus sequence was derived by comparing each base between the four core-type sites. Y, T or C; N, any base. (B) Alignment of six arm-type sites as determined by DNase

    Techniques Used: Footprinting, Sequencing, Derivative Assay

    IntN1 and Orf2x protection on attN1 as determined by DNase I footprinting analysis. The black boxes indicate IntN1 core-type sites, and the gray boxes denote arm-type sites. The green box represents the common core region, and the vertical arrows indicate
    Figure Legend Snippet: IntN1 and Orf2x protection on attN1 as determined by DNase I footprinting analysis. The black boxes indicate IntN1 core-type sites, and the gray boxes denote arm-type sites. The green box represents the common core region, and the vertical arrows indicate

    Techniques Used: Footprinting

    24) Product Images from "Interactions of NBU1 IntN1 and Orf2x Proteins with Attachment Site DNA"

    Article Title: Interactions of NBU1 IntN1 and Orf2x Proteins with Attachment Site DNA

    Journal: Journal of Bacteriology

    doi: 10.1128/JB.01011-13

    (A) DNase I footprint of IntN1 on the top strand of attL . Panel 1 shows a sequencing ladder generated using dideoxy sequencing reactions with the same 6-FAM-labeled primer used to make the footprinting substrate; green denotes adenine, blue denotes cytosine,
    Figure Legend Snippet: (A) DNase I footprint of IntN1 on the top strand of attL . Panel 1 shows a sequencing ladder generated using dideoxy sequencing reactions with the same 6-FAM-labeled primer used to make the footprinting substrate; green denotes adenine, blue denotes cytosine,

    Techniques Used: Sequencing, Generated, Labeling, Footprinting

    (A) DNase I footprint of Orf2x on the bottom strand of attL . Fluorescently labeled attL DNA was PCR amplified and used in footprinting experiments with Orf2x. The top panel shows a sequencing ladder generated using dideoxy sequencing reactions with the
    Figure Legend Snippet: (A) DNase I footprint of Orf2x on the bottom strand of attL . Fluorescently labeled attL DNA was PCR amplified and used in footprinting experiments with Orf2x. The top panel shows a sequencing ladder generated using dideoxy sequencing reactions with the

    Techniques Used: Labeling, Polymerase Chain Reaction, Amplification, Footprinting, Sequencing, Generated

    (A) Alignment of four core-type sites as determined by DNase I footprinting. The consensus sequence was derived by comparing each base between the four core-type sites. Y, T or C; N, any base. (B) Alignment of six arm-type sites as determined by DNase
    Figure Legend Snippet: (A) Alignment of four core-type sites as determined by DNase I footprinting. The consensus sequence was derived by comparing each base between the four core-type sites. Y, T or C; N, any base. (B) Alignment of six arm-type sites as determined by DNase

    Techniques Used: Footprinting, Sequencing, Derivative Assay

    IntN1 and Orf2x protection on attN1 as determined by DNase I footprinting analysis. The black boxes indicate IntN1 core-type sites, and the gray boxes denote arm-type sites. The green box represents the common core region, and the vertical arrows indicate
    Figure Legend Snippet: IntN1 and Orf2x protection on attN1 as determined by DNase I footprinting analysis. The black boxes indicate IntN1 core-type sites, and the gray boxes denote arm-type sites. The green box represents the common core region, and the vertical arrows indicate

    Techniques Used: Footprinting

    25) Product Images from "Identification of Viral Peptide Fragments for Vaccine Development"

    Article Title: Identification of Viral Peptide Fragments for Vaccine Development

    Journal: Viral Applications of Green Fluorescent Protein

    doi: 10.1007/978-1-59745-559-6_18

    Fragment library construction for SARS-CoV spike.  a  Fragmentation of target gene digested by DNase I.  b  Reassembled gene fragments..
    Figure Legend Snippet: Fragment library construction for SARS-CoV spike. a Fragmentation of target gene digested by DNase I. b Reassembled gene fragments..

    Techniques Used:

    26) Product Images from "Identification of Viral Peptide Fragments for Vaccine Development"

    Article Title: Identification of Viral Peptide Fragments for Vaccine Development

    Journal: Viral Applications of Green Fluorescent Protein

    doi: 10.1007/978-1-59745-559-6_18

    Fragment library construction for SARS-CoV spike.  a  Fragmentation of target gene digested by DNase I.  b  Reassembled gene fragments..
    Figure Legend Snippet: Fragment library construction for SARS-CoV spike. a Fragmentation of target gene digested by DNase I. b Reassembled gene fragments..

    Techniques Used:

    27) Product Images from "DNase I aggravates islet β-cell apoptosis in type 2 diabetes"

    Article Title: DNase I aggravates islet β-cell apoptosis in type 2 diabetes

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2016.5102

    DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Culture, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Flow Cytometry, Cytometry, Standard Deviation

    Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.
    Figure Legend Snippet: Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.

    Techniques Used: Immunohistochemistry, Staining

    DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Counting, Expressing, Western Blot, Real-time Polymerase Chain Reaction, TUNEL Assay, Flow Cytometry, Cytometry, Standard Deviation

    DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P
    Figure Legend Snippet: DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P

    Techniques Used: Activity Assay, Standard Deviation

    28) Product Images from "DNase I aggravates islet β-cell apoptosis in type 2 diabetes"

    Article Title: DNase I aggravates islet β-cell apoptosis in type 2 diabetes

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2016.5102

    DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Culture, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Flow Cytometry, Cytometry, Standard Deviation

    Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.
    Figure Legend Snippet: Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.

    Techniques Used: Immunohistochemistry, Staining

    DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Counting, Expressing, Western Blot, Real-time Polymerase Chain Reaction, TUNEL Assay, Flow Cytometry, Cytometry, Standard Deviation

    DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P
    Figure Legend Snippet: DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P

    Techniques Used: Activity Assay, Standard Deviation

    29) Product Images from "Transcriptional regulatory logic of the diurnal cycle in the mouse liver"

    Article Title: Transcriptional regulatory logic of the diurnal cycle in the mouse liver

    Journal: PLoS Biology

    doi: 10.1371/journal.pbio.2001069

    DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.
    Figure Legend Snippet: DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.

    Techniques Used: Chromatin Immunoprecipitation, DNA Sequencing, Activation Assay

    Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].
    Figure Legend Snippet: Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].

    Techniques Used: Binding Assay

    Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p
    Figure Legend Snippet: Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p

    Techniques Used: Mouse Assay, Chromatin Immunoprecipitation, DNA Sequencing, Binding Assay, Expressing

    BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.
    Figure Legend Snippet: BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation, DNA Sequencing, Mouse Assay

    Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p
    Figure Legend Snippet: Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p

    Techniques Used: Mouse Assay, Western Blot

    Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p
    Figure Legend Snippet: Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p

    Techniques Used: Genome Wide

    30) Product Images from "Transcriptional regulatory logic of the diurnal cycle in the mouse liver"

    Article Title: Transcriptional regulatory logic of the diurnal cycle in the mouse liver

    Journal: PLoS Biology

    doi: 10.1371/journal.pbio.2001069

    DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.
    Figure Legend Snippet: DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.

    Techniques Used: Chromatin Immunoprecipitation, DNA Sequencing, Activation Assay

    Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].
    Figure Legend Snippet: Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].

    Techniques Used: Binding Assay

    Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p
    Figure Legend Snippet: Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p

    Techniques Used: Mouse Assay, Chromatin Immunoprecipitation, DNA Sequencing, Binding Assay, Expressing

    BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.
    Figure Legend Snippet: BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation, DNA Sequencing, Mouse Assay

    Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p
    Figure Legend Snippet: Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p

    Techniques Used: Mouse Assay, Western Blot

    Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p
    Figure Legend Snippet: Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p

    Techniques Used: Genome Wide

    31) Product Images from "Transcriptional regulatory logic of the diurnal cycle in the mouse liver"

    Article Title: Transcriptional regulatory logic of the diurnal cycle in the mouse liver

    Journal: PLoS Biology

    doi: 10.1371/journal.pbio.2001069

    DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.
    Figure Legend Snippet: DNase I hypersensitivity is rhythmic during diurnal cycles in mouse liver. A. DNase I hypersensitivity, RNA polymerase II (Pol II) density, and H3K27ac enrichment at the Dbp locus. The DNase I track shows the frequency at which nucleotide-resolved DNase I cuts, while H3K27ac and Pol II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signals are smoothed over 100 bp. All time points are overlaid. The center of each DNase I hypersensitive site (DHS)-enriched region is indicated by vertical ticks (three sites near the TSS are numbered). B. Zoom-in around the transcription start site (TSS) of Dbp (the three TSSs in A are marked) reveals DNase I cuts in between H3K27ac-marked nucleosomes. Both DNase I and H3K27ac signals are maximal at ZT6–ZT10 and minimal at ZT22, consistent with BMAL1-mediated activation of Dbp transcription (absolute signal is highest for site 2, while amplitude is highest for site 3; see panel D). The red and green lines (identical in all subgraphs) show the max signal over the time points at each position and serve as a guide to the eye. C. Quantification of read counts (in log 2 units) for DNase I cuts (in windows of ±300 bp) and Pol II and H3K27Ac ChIP-seq data (in windows of ±1,000 bp) centered on the Dbp TSS using cosine fits. Cosine fits show a common estimated peak time around ZT10 (marked by the inverted triangles). Peak-to-trough amplitudes are about 16-fold for Pol II and approximately 4-fold for both DNase I and H3K27ac. D. Phases and amplitudes of all DHS sites located in the neighborhood of the Dbp gene (nearest TSS association according to annotation). Distances from the center of the plot indicate fitted log 2 amplitudes, and angles (clockwise from ZT0) indicate peak times. We observed that all regions oscillate around a common phase of ZT10. Of the three sites near the TSS (numbered 1–3), site 3 has the highest amplitude. E–H. Idem as A–D but for Npas2 , which has an opposite phase to Dbp (i.e., Npas2 peaks near ZT22). Oscillatory amplitudes are generally larger for Npas2 compared to Dbp . G shows quantification of the signal at the TSS as in panel C.

    Techniques Used: Chromatin Immunoprecipitation, DNA Sequencing, Activation Assay

    Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].
    Figure Legend Snippet: Location-dependent footprint characteristics of DNase I Hypersensitive Sites (DHSs). A. Visualization of DNase I signal (red) around the Rev-erbα promoter with the footprints (detected by Wellington) annotated in black, on top. This region contains BMAL1-binding sites (blue) with E-box motifs, annotated on the bottom line, which is marked by a characteristic footprint. The DNase I cleavage pattern is lower at the binding site, reflecting protection of the DNA from digestion, whereas high signals are observed on the edges of the binding site. B. Number of footprints within DHSs (±300 bp around the peak center). TSS regions contain more footprints on average. More than half of distal regions contain a footprint. C. Number of footprints detected in DHSs in function of (relative) H3K36me3 signal [ 12 ].

    Techniques Used: Binding Assay

    Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p
    Figure Legend Snippet: Chromatin accessibility in Bmal1 -/- mice at ZT6 is generally similar as in the Wild-Type (WT) mice but is lower at BMAL1 sites. A. The Rev-erbα (left) and Gsk3a (right) promoters. DNase I signal (in red) is strongly reduced in Bmal1 -/- mice at sites bound by CLOCK:BMAL1 in WT mice (BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) signal in blue) in the Rev-erbα promoter but is similar in WT and Bmal1 -/- mice at the Gsk3a promoter that are not bound by BMAL1. The vertical scale is the same for all three DNase I tracks, as well as for both BMAL1 ChiP-seq tracks. Wild-type ZT18 signals are lower (about half) than at ZT6 in both genes but not as low as in the Bmal1 -/- mice. B. Comparison of DNase I signals at ZT6 in Bmal1 - /- versus WT mice. All DNase I hypersensitive sites (DHSs) overlapping BMAL1 ChIP-seq peaks in [ 17 ] are shown ( n = 1,555). The dashed lines indicate 4-fold difference. C. Boxplots showing DNase I intensity at the same sites as in B, at peak (ZT6) and trough (ZT18) activities of BMAL1 in the WT, and at ZT6 in Bmal1 -/- mice for all BMAL1-binding sites (green), BMAL1 sites with an associated expression phase between ZT2 and ZT10 (orange), and with a tandem E-box (grey). All pairwise comparisons (within the same color) between either ZT6 versus ZT18 or ZT6 versus ZT6 Bmal1 -/- are significant ( p

    Techniques Used: Mouse Assay, Chromatin Immunoprecipitation, DNA Sequencing, Binding Assay, Expressing

    BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.
    Figure Legend Snippet: BMAL1 footprints indicate temporally changing protein–DNA complexes, consistent with binding of a heterotetramer to DNA. A. Genomic profiles of DNase I cuts around double E-boxes with a spacer of 6 bp (E1-E2 sp6). We selected n = 249 E1-E2 sp6 motifs overlapping a BMAL1 chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) peak and show the average of profiles for loci classified as bound by the mixture model (posterior probability > 0.5). At ZT6, we observed that nucleotides around both E-boxes are protected. In contrast, at ZT18, the width of the protected region is reduced by approximately half, with the second E-box no longer protected from digestion. The signals are anchored to the motif position. Orientation of sites and signals is according to the best match to the E1-E2 sp6 motif. In Bmal1 -/- , only one E-box appears occupied. B. Width (left-side y -axis, green) of the protected region in WT and in Bmal1 -/- mice for E1-E2 sp6 motifs occupied by BMAL1. Fraction of predicted occupied sites is shown in blue (right-side y -axis). C. Two views of the 3-D computational model of the CLOCK:BMAL1 heterotetramer showing two heterodimers of CLOCK:BMAL1 occupying an E1-E2 sp6 site. The two heterodimers are shown in green and blue, while darker green and darker blue correspond to BMAL1 and lighter colors to CLOCK proteins. Information content along the DNA strands is shown in grey with highly constrained nucleotides of the motif in red. D. Zoom on the interacting residuals on the PAS-B domain of CLOCK implicated in the heterotetramer formation.

    Techniques Used: Binding Assay, Chromatin Immunoprecipitation, DNA Sequencing, Mouse Assay

    Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p
    Figure Legend Snippet: Distal DNase I Hypersensitive Sites (DHSs) help identify diurnally active transcription regulators. A. Scheme of the linear model to infer active transcription regulators: transcription factor (TF) motifs in DHSs within a symmetric window around active transcription start sites (TSSs) are used to explain diurnal rhythms in transcription. B. Fraction of explained temporal variance (deviance ratio) in RNA polymerase II (Pol II) loading (at the TSS of all actives genes) for WT and Bmal1 -/- mice, in function of the window size (radius) for DHS inclusion, shows a maximum at around 50 kb. Here, α = 0 was used in the glmnet ( Materials and methods ). C–D. Inferred TF motif activities for WT and in Bmal1 -/- mice shown with amplitudes (distance from center) and peak times (clockwise, ZT0 at the top) using a window size of 50 kb. All 819 (WT) and 629 ( Bmal1 -/- ) motifs (overlap is 427) with nonzero activities are shown. Note though that most activities are very small and cluster in the center. Certain families of TFs are indicated in colors (full results are provided in S4 Table ). Radial scale for activities is arbitrary but comparable in C and D. E. Quantification of western blots for pCREB (Ser 133 phosphorylation) and CREB in WT and Bmal1 - /- genotypes (log 2 (pCREB/CREB)). Nuclear extracts from four independent livers were harvested every 2 h. Both genotypes showed a significant oscillation ( p

    Techniques Used: Mouse Assay, Western Blot

    Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p
    Figure Legend Snippet: Genome-wide rhythms in DNase I signals are synchronous with RNA Polymerase II (Pol II) transcription and histone acetylation. A. Number of DNase I hypersensitive sites (DHSs) with statistically significant cycling DNase I signals (left), H3K27ac signals (middle), or Pol II signals (right) at three different thresholds ( p

    Techniques Used: Genome Wide

    32) Product Images from "Zinc Blockade of SOS Response Inhibits Horizontal Transfer of Antibiotic Resistance Genes in Enteric Bacteria"

    Article Title: Zinc Blockade of SOS Response Inhibits Horizontal Transfer of Antibiotic Resistance Genes in Enteric Bacteria

    Journal: Frontiers in Cellular and Infection Microbiology

    doi: 10.3389/fcimb.2018.00410

    Role of the SOS response in horizontal transfer of beta-lactam resistance from E_clo_Niagara to susceptible E. coli strain EC43. (A) Induction and inhibition of inter-species gene transfer. E_clo_Niagara and E. coli EC43 were both treated separately with ciprofloxacin to induce the SOS response, then mixed and allowed to co-incubate for 20 h. The mixtures were plated on LB + ceftazidime + chloramphenicol, and examined under UV light for green fluorescing colonies resistant to both antibiotics. Since the colonies fitting the above description all tested as being E. coli , not Enterobacter, the frequency of emergence of such colonies was calculated relative to the number of EC43 bacteria placed into the original mixture. Zinc acetate concentration was 0.2 mM; * significantly increased compared to control, ** significantly decreased compared to the conditions receiving ciprofloxacin. (B) Effect of ciprofloxacin applied to E_clo_Niagara alone, E. coli EC43 alone, or both strains, on the horizontal gene transfer. The concentration of zinc used in (B) , far-right column, was 0.2 mM; * significantly increased compared to control, ** significantly decreased compared to the conditions receiving ciprofloxacin. (C) Effect of ciprofloxacin and zinc on horizontal gene transfer, with the transconjugant frequency expressed on a log scale. 0.1 mM zinc was used in panel C; * significantly increased compared to control, †significantly decreased compared to the conditions receiving ciprofloxacin. (D) Effect of zinc and DNase I on release of double-stranded DNA into culture supernatant; * significantly decreased compared to the plus cipro condition. (E) Effect of zinc and DNase I on frequency of emergence of putative transconjugants (green fluorescing colonies resistant to both antibiotics), showing that zinc, but not DNase, blocked the transfer of beta-lactam resistance to the E. coli strain. * significantly decreased compared to the condition receiving ciprofloxacin alone. †There were no Ceftaz R , Chloram R E. coli colonies in the zinc-treated group, so the data points shown are calculated as if 1 colony had appeared.
    Figure Legend Snippet: Role of the SOS response in horizontal transfer of beta-lactam resistance from E_clo_Niagara to susceptible E. coli strain EC43. (A) Induction and inhibition of inter-species gene transfer. E_clo_Niagara and E. coli EC43 were both treated separately with ciprofloxacin to induce the SOS response, then mixed and allowed to co-incubate for 20 h. The mixtures were plated on LB + ceftazidime + chloramphenicol, and examined under UV light for green fluorescing colonies resistant to both antibiotics. Since the colonies fitting the above description all tested as being E. coli , not Enterobacter, the frequency of emergence of such colonies was calculated relative to the number of EC43 bacteria placed into the original mixture. Zinc acetate concentration was 0.2 mM; * significantly increased compared to control, ** significantly decreased compared to the conditions receiving ciprofloxacin. (B) Effect of ciprofloxacin applied to E_clo_Niagara alone, E. coli EC43 alone, or both strains, on the horizontal gene transfer. The concentration of zinc used in (B) , far-right column, was 0.2 mM; * significantly increased compared to control, ** significantly decreased compared to the conditions receiving ciprofloxacin. (C) Effect of ciprofloxacin and zinc on horizontal gene transfer, with the transconjugant frequency expressed on a log scale. 0.1 mM zinc was used in panel C; * significantly increased compared to control, †significantly decreased compared to the conditions receiving ciprofloxacin. (D) Effect of zinc and DNase I on release of double-stranded DNA into culture supernatant; * significantly decreased compared to the plus cipro condition. (E) Effect of zinc and DNase I on frequency of emergence of putative transconjugants (green fluorescing colonies resistant to both antibiotics), showing that zinc, but not DNase, blocked the transfer of beta-lactam resistance to the E. coli strain. * significantly decreased compared to the condition receiving ciprofloxacin alone. †There were no Ceftaz R , Chloram R E. coli colonies in the zinc-treated group, so the data points shown are calculated as if 1 colony had appeared.

    Techniques Used: Inhibition, Concentration Assay

    33) Product Images from "DNA Builds and Strengthens the Extracellular Matrix in Myxococcus xanthus Biofilms by Interacting with Exopolysaccharides"

    Article Title: DNA Builds and Strengthens the Extracellular Matrix in Myxococcus xanthus Biofilms by Interacting with Exopolysaccharides

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0051905

    Mechanical strength, anti-disruptive properties and nanomechanical adhesive characteristics recorded using force-separation curves of the M. xanthus starvation biofilm matrix with or without eDNA. In panel A, DK1622 biofilms without DNase I (black bar) and with DNase I (grey bar) were established over a 24 hr time period in MOPS buffer and biomass was measured as crystal violet optical density (No-treatment control). The changes of biomass in these two kinds of biofilms after sonication or SDS treatment, respectively, are also shown. In panel B, representative force curves measured by AFM on DK1622 24 hr starvation biofilm matrix (curve I), matrix treated with DNase I (curve II) and bare portion of the substrate after the tip was used (curve III). Force-separation curves were recorded as “approach” (blue) and “retraction” (red) curves.
    Figure Legend Snippet: Mechanical strength, anti-disruptive properties and nanomechanical adhesive characteristics recorded using force-separation curves of the M. xanthus starvation biofilm matrix with or without eDNA. In panel A, DK1622 biofilms without DNase I (black bar) and with DNase I (grey bar) were established over a 24 hr time period in MOPS buffer and biomass was measured as crystal violet optical density (No-treatment control). The changes of biomass in these two kinds of biofilms after sonication or SDS treatment, respectively, are also shown. In panel B, representative force curves measured by AFM on DK1622 24 hr starvation biofilm matrix (curve I), matrix treated with DNase I (curve II) and bare portion of the substrate after the tip was used (curve III). Force-separation curves were recorded as “approach” (blue) and “retraction” (red) curves.

    Techniques Used: Sonication

    eDNA in M. xanthus non-developmental starvation biofilms. M. xanthus DK1622 biofilm structures formed in MOPS buffer at 24 hr (panels A and B) and DNase I treated biofilm (panels C and D) were counterstained with SYTOX orange (red) and SYTO9 (green). Panels A and C are the single channel images (SYTOX orange), and panels B and D are the overlaid images. M. xanthus DK10547 with a GFP label (green) formed starvation biofilms (panels E and F) in MOPs buffer at 24 hr was counterstained with SYTOX orange (red) and FM 4-64 (blue). Panel E is the single channel image (FM 4-64), and panel F is the overlaid image. The bars represent 50 µm in panels A–D and 10 µm in panels E and F.
    Figure Legend Snippet: eDNA in M. xanthus non-developmental starvation biofilms. M. xanthus DK1622 biofilm structures formed in MOPS buffer at 24 hr (panels A and B) and DNase I treated biofilm (panels C and D) were counterstained with SYTOX orange (red) and SYTO9 (green). Panels A and C are the single channel images (SYTOX orange), and panels B and D are the overlaid images. M. xanthus DK10547 with a GFP label (green) formed starvation biofilms (panels E and F) in MOPs buffer at 24 hr was counterstained with SYTOX orange (red) and FM 4-64 (blue). Panel E is the single channel image (FM 4-64), and panel F is the overlaid image. The bars represent 50 µm in panels A–D and 10 µm in panels E and F.

    Techniques Used:

    eDNA in M. xanthus submerged fruiting bodies. M. xanthus DK1622 fruiting body formed in submerged culture at 24 hr after starvation was initiated (panels A–C) and DNase I treated submerged fruiting body (panel D) were counterstained with SYTOX orange (red) and SYTO9 (green). Panels A is the single channel image (SYTOX orange), and panels B–D are the overlaid images. Panel C showed a magnified portion of panel B indicated by a white pane. M. xanthus DK10547 with a GFP label (green) formed fruiting body (panels E and F) in MOPs buffer at 24 hr was counterstained with SYTOX orange (red) and FM 4-64 (blue). Panel E is the single channel image (FM 4-64), and panel F is the overlaid image. Panel G shows a 48 hr submerged fruiting body of DK1622 stained with SYTOX orange, and panel H shows a trail structure in a 48 hr submerged culture of DK1622 stained with SYTOX orange and SYTO9. The bars represent 50 µm in panels A–D, 10 µm in panels E, F and H, and 20 µm in panel G.
    Figure Legend Snippet: eDNA in M. xanthus submerged fruiting bodies. M. xanthus DK1622 fruiting body formed in submerged culture at 24 hr after starvation was initiated (panels A–C) and DNase I treated submerged fruiting body (panel D) were counterstained with SYTOX orange (red) and SYTO9 (green). Panels A is the single channel image (SYTOX orange), and panels B–D are the overlaid images. Panel C showed a magnified portion of panel B indicated by a white pane. M. xanthus DK10547 with a GFP label (green) formed fruiting body (panels E and F) in MOPs buffer at 24 hr was counterstained with SYTOX orange (red) and FM 4-64 (blue). Panel E is the single channel image (FM 4-64), and panel F is the overlaid image. Panel G shows a 48 hr submerged fruiting body of DK1622 stained with SYTOX orange, and panel H shows a trail structure in a 48 hr submerged culture of DK1622 stained with SYTOX orange and SYTO9. The bars represent 50 µm in panels A–D, 10 µm in panels E, F and H, and 20 µm in panel G.

    Techniques Used: Staining

    34) Product Images from "A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse ?-globin locus"

    Article Title: A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse ?-globin locus

    Journal: Proceedings of the National Academy of Sciences of the United States of America

    doi:

    DNase I hypersensitivity analysis upstream of the deleted region. ( A ) Map of the far upstream region of the mouse β-globin locus. The positions of the two new HSs are indicated. ( B ) Analysis of hypersensitive sites in murine erythroleukemia cells and L929 cells. The parental band is a 4.3-kb Bam HI to Eco RI fragment. The position of the probe, a 285-bp Afl III to Eco RI fragment, is shown in A . ( C ) Analysis of upstream hypersensitive sites in spleen and liver chromatin of phenylhydrazine-treated mice. The parental band is a 6.7-kb Eco RI to Eco RI fragment, and the probe described in B was used. Mice used for the DNase I series shown were either wt ( diffuse/diffuse genotype) or homozygous for the 11-kb mutation ( diffuse* ΔN/ diffuse* ΔN genotype).
    Figure Legend Snippet: DNase I hypersensitivity analysis upstream of the deleted region. ( A ) Map of the far upstream region of the mouse β-globin locus. The positions of the two new HSs are indicated. ( B ) Analysis of hypersensitive sites in murine erythroleukemia cells and L929 cells. The parental band is a 4.3-kb Bam HI to Eco RI fragment. The position of the probe, a 285-bp Afl III to Eco RI fragment, is shown in A . ( C ) Analysis of upstream hypersensitive sites in spleen and liver chromatin of phenylhydrazine-treated mice. The parental band is a 6.7-kb Eco RI to Eco RI fragment, and the probe described in B was used. Mice used for the DNase I series shown were either wt ( diffuse/diffuse genotype) or homozygous for the 11-kb mutation ( diffuse* ΔN/ diffuse* ΔN genotype).

    Techniques Used: Mouse Assay, Mutagenesis

    DNase I hypersensitivity analysis downstream of the deleted region. The diagram shows a map of the upstream region of the mouse β-globin locus. The positions of the ɛ y gene, the 5′ HSs, and two 5′ OR genes are indicated. The locations of the fragments used for hypersensitivity assays are shown, and the positions of Bam HI (B) and Pst I (P) sites are indicated. The dotted portion of the 27-kb Bam HI fragment indicates the region that was deleted. The probe positions on the fragments are indicated by gray boxes. ( Left ) 5′HS 4 was detected by using a 27-kb Bam HI parental fragment (16 kb for homozygotes with the deletion), with a 557-bp Eco RI to Sac I fragment as a probe. ( Center ) 5′HS 3 was detected by using a 5.5-kb Bam HI fragment, with a 359-bp Ssp I to Bgl II fragment as a probe. ( Right ) 5′HS 1 and 5′HS 2 were detected by using a 13.5-kb Pst ). Mice used for the DNase I series shown were either wt ( diffuse/diffuse genotype) or homozygous for the 11-kb mutation ( diffuse* ΔN/ diffuse* ΔN genotype).
    Figure Legend Snippet: DNase I hypersensitivity analysis downstream of the deleted region. The diagram shows a map of the upstream region of the mouse β-globin locus. The positions of the ɛ y gene, the 5′ HSs, and two 5′ OR genes are indicated. The locations of the fragments used for hypersensitivity assays are shown, and the positions of Bam HI (B) and Pst I (P) sites are indicated. The dotted portion of the 27-kb Bam HI fragment indicates the region that was deleted. The probe positions on the fragments are indicated by gray boxes. ( Left ) 5′HS 4 was detected by using a 27-kb Bam HI parental fragment (16 kb for homozygotes with the deletion), with a 557-bp Eco RI to Sac I fragment as a probe. ( Center ) 5′HS 3 was detected by using a 5.5-kb Bam HI fragment, with a 359-bp Ssp I to Bgl II fragment as a probe. ( Right ) 5′HS 1 and 5′HS 2 were detected by using a 13.5-kb Pst ). Mice used for the DNase I series shown were either wt ( diffuse/diffuse genotype) or homozygous for the 11-kb mutation ( diffuse* ΔN/ diffuse* ΔN genotype).

    Techniques Used: Mouse Assay, Mutagenesis

    35) Product Images from "Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin"

    Article Title: Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin

    Journal: Clinical and Experimental Immunology

    doi: 10.1111/j.1365-2249.2010.04289.x

    Mapping of the DNase I hypersensitive site. (a) Genomic DNA was migrated overnight in a 0·8% agarose gel then transferred to a nylon membrane and hybridized overnight with a probe specific for the 10·2 Kb fragment of interest. Results are representative of two independent experiments. (b) Interpolation of hypersensitive site (HS) in untreated CEMC7A cells. The hypersensitive site spans ∼911 base pairs but is centred on the first intron.
    Figure Legend Snippet: Mapping of the DNase I hypersensitive site. (a) Genomic DNA was migrated overnight in a 0·8% agarose gel then transferred to a nylon membrane and hybridized overnight with a probe specific for the 10·2 Kb fragment of interest. Results are representative of two independent experiments. (b) Interpolation of hypersensitive site (HS) in untreated CEMC7A cells. The hypersensitive site spans ∼911 base pairs but is centred on the first intron.

    Techniques Used: Agarose Gel Electrophoresis

    The DNase I hypersensitive site is a cell type-specific enhancer. Reporter assays of the intronic constructs. (a) The first intron of the MIF gene was cloned into the pGL3 promoter vector (SV40) in both the sense and anti-sense orientation. As a positive control of enhancer activity the pGL3 control vector was used, which possesses an SV40 enhancer together with the SV40 promoter. The plasmids were transfected in CEMC7A cells and cells were left to incubate for 24 h before harvest and luciferase assay. * P
    Figure Legend Snippet: The DNase I hypersensitive site is a cell type-specific enhancer. Reporter assays of the intronic constructs. (a) The first intron of the MIF gene was cloned into the pGL3 promoter vector (SV40) in both the sense and anti-sense orientation. As a positive control of enhancer activity the pGL3 control vector was used, which possesses an SV40 enhancer together with the SV40 promoter. The plasmids were transfected in CEMC7A cells and cells were left to incubate for 24 h before harvest and luciferase assay. * P

    Techniques Used: Construct, Clone Assay, Plasmid Preparation, Positive Control, Activity Assay, Transfection, Luciferase

    36) Product Images from "Distinct Functions of Dispersed GATA Factor Complexes at an Endogenous Gene Locus"

    Article Title: Distinct Functions of Dispersed GATA Factor Complexes at an Endogenous Gene Locus

    Journal: Molecular and Cellular Biology

    doi: 10.1128/MCB.01033-06

    DNase I hypersensitivity at the −77 region. Nuclei were isolated from untreated or tamoxifen-treated (23 h) G1E-ER-GATA-1 cells and digested with increasing concentrations of DNase I. After cleavage of purified genomic DNA with BanI, fragments
    Figure Legend Snippet: DNase I hypersensitivity at the −77 region. Nuclei were isolated from untreated or tamoxifen-treated (23 h) G1E-ER-GATA-1 cells and digested with increasing concentrations of DNase I. After cleavage of purified genomic DNA with BanI, fragments

    Techniques Used: Isolation, Purification

    37) Product Images from "Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis"

    Article Title: Extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval Strongyloides stercoralis

    Journal: Microbes and infection / Institut Pasteur

    doi: 10.1016/j.micinf.2014.02.012

    NETs are required for larval killing by human neutrophils in vitro. A) Human macrophages (Mϕ) and neutrophils (PMN) cultured in vitro with 50 larvae (L3) for 48 h. The cultures were treated with 100 U/ml of DNase I to block NET formation and assessed
    Figure Legend Snippet: NETs are required for larval killing by human neutrophils in vitro. A) Human macrophages (Mϕ) and neutrophils (PMN) cultured in vitro with 50 larvae (L3) for 48 h. The cultures were treated with 100 U/ml of DNase I to block NET formation and assessed

    Techniques Used: In Vitro, Cell Culture, Blocking Assay

    38) Product Images from "A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter"

    Article Title: A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter

    Journal: Genes and immunity

    doi: 10.1038/gene.2008.67

    Mapping of the novel hypersensitivity site (HSS) to the CD154 promoter and a sequence conserved region just upstream. ( a ) Jurkat D1.1 nuclei were digested with 0 (lanes 1–3, 6–8), 2.5 (lane 4) or 3 (lane 5) μg ml −1  of DNase I. Genomic DNA was then digested with nothing (lane 8),  Bam HI alone (lanes 3–5), or  Bam HI plus the following:  Hin dIII (lane 1),  Sna BI (lane 2),  Xba I (lane 6) or  Pst I (lane 7). HSS 1 (CD154 promoter) and HSS 2 (novel upstream element) are depicted by arrows. Restriction enzymes and associated base pair sizes of fragments are listed to the sides. ( b ) A graphic depiction (VISTA map) of the degree of DNA sequence conservation ( y  axis ranges from 50–100% identity) between mouse and human of the regions flanking HSS 1 (CD154 promoter) and HSS 2 (upstream element).
    Figure Legend Snippet: Mapping of the novel hypersensitivity site (HSS) to the CD154 promoter and a sequence conserved region just upstream. ( a ) Jurkat D1.1 nuclei were digested with 0 (lanes 1–3, 6–8), 2.5 (lane 4) or 3 (lane 5) μg ml −1 of DNase I. Genomic DNA was then digested with nothing (lane 8), Bam HI alone (lanes 3–5), or Bam HI plus the following: Hin dIII (lane 1), Sna BI (lane 2), Xba I (lane 6) or Pst I (lane 7). HSS 1 (CD154 promoter) and HSS 2 (novel upstream element) are depicted by arrows. Restriction enzymes and associated base pair sizes of fragments are listed to the sides. ( b ) A graphic depiction (VISTA map) of the degree of DNA sequence conservation ( y axis ranges from 50–100% identity) between mouse and human of the regions flanking HSS 1 (CD154 promoter) and HSS 2 (upstream element).

    Techniques Used: Sequencing

    39) Product Images from "Identification of Viral Peptide Fragments for Vaccine Development"

    Article Title: Identification of Viral Peptide Fragments for Vaccine Development

    Journal: Viral Applications of Green Fluorescent Protein

    doi: 10.1007/978-1-59745-559-6_18

    Fragment library construction for SARS-CoV spike.  a  Fragmentation of target gene digested by DNase I.  b  Reassembled gene fragments..
    Figure Legend Snippet: Fragment library construction for SARS-CoV spike. a Fragmentation of target gene digested by DNase I. b Reassembled gene fragments..

    Techniques Used:

    40) Product Images from "DNase I aggravates islet β-cell apoptosis in type 2 diabetes"

    Article Title: DNase I aggravates islet β-cell apoptosis in type 2 diabetes

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2016.5102

    DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I knockdown can reduce the apoptosis of cells cultured with high glucose. (A) Knockdown efficiency examined by western blotting. Expression of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Apoptotic rate examined by flow cytometry [(a), normal; (b), high glucose; and (c), siRNA group]. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Culture, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Flow Cytometry, Cytometry, Standard Deviation

    Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.
    Figure Legend Snippet: Immunohistochemistry of the human pancreas. Pancreatic tissues from patients with pancreatic cancer, with or without type 2 diabetes were stained with insulin, glucagon, and DNase I. (A) Insulin, (B) glucagon and (C) DNase I staining of tissues from patients without type 2 diabetes. (D) Insulin, (E) glucagon and (F) DNase I staining of tissues from patients with type 2 diabetes. DNase I, deoxyribonuclease I.

    Techniques Used: Immunohistochemistry, Staining

    DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P
    Figure Legend Snippet: DNase I combined with high glucose induced cell apoptosis. (A) Cell viability assessed by the Cell Counting Kit-8 assay. The expression levels of DNase I, Bcl-2 and caspase-3 in the three groups were examined by (B) western blotting and (C) reverse transcription-quantitative polymerase chain reaction. (D) Cell apoptosis results from (a) the terminal deoxynucleotidyl transferase dUTP nick-end labeling assay and (b) flow cytometry. Data are expressed as the mean ± standard deviation from three independent experiments. * P

    Techniques Used: Cell Counting, Expressing, Western Blot, Real-time Polymerase Chain Reaction, TUNEL Assay, Flow Cytometry, Cytometry, Standard Deviation

    DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P
    Figure Legend Snippet: DNase I activity in human serum. (A) DNase I activity in human serum. (B) The correlation of DNase I activity with calcium. (C) DNase I activity Spearman correlation coefficient. All data are presented as the mean ± standard deviation. *** P

    Techniques Used: Activity Assay, Standard Deviation

    Related Articles

    Concentration Assay:

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro
    Article Snippet: .. DNase I (Worthington Biochemicals) was added to a concentration of 8 ng/ml, and incubation was continued for an additional 2 min, after which the cleavage reaction was terminated by addition of an equal volume of a stop solution (0.2 M NaCl, 30 mM EDTA, 1% sodium dodecyl sulfate, and 100 μg of glycogen/ml). .. DNA cleavage products were extracted with phenol-chloroform, precipitated with ethanol, and analyzed on a 6% polyacrylamide DNA sequencing gel.

    Incubation:

    Article Title: Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans
    Article Snippet: .. As controls (i) NETs were mock-digested with nuclease-free RPMI and (ii) unstimulated neutrophils that did not release NETs were washed twice and incubated with RPMI containing 10 U/ml Dnase-1 for 20 min at 37°C. .. Four samples out of 4 wells were pooled, acetone precipitated, solubilized in 120 µl SDS loading buffer and boiled for 3 min. To account for potential protein loss due to proteolytic activity in the samples a complete purification procedure was performed in the presence of protease inhibitor cocktail (Sigma P1860; 1∶200) added to the wells 2 h after stimulation start as described above.

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro
    Article Snippet: .. DNase I (Worthington Biochemicals) was added to a concentration of 8 ng/ml, and incubation was continued for an additional 2 min, after which the cleavage reaction was terminated by addition of an equal volume of a stop solution (0.2 M NaCl, 30 mM EDTA, 1% sodium dodecyl sulfate, and 100 μg of glycogen/ml). .. DNA cleavage products were extracted with phenol-chloroform, precipitated with ethanol, and analyzed on a 6% polyacrylamide DNA sequencing gel.

    other:

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain
    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain
    Article Snippet: [ ] [ ] Stalder J., Larsen,A., Engel,J.D., Dolan,M., Groudine,M. and Weintraub,H. (1980) Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNase I.

    Article Title: Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans
    Article Snippet: Supernatants were removed, NETs were washed twice with 1 ml RPMI and digested with 500 µl 10 U/ml DNase-1 each.

    Staining:

    Article Title: Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting
    Article Snippet: .. These were then digested at 37 °C for 15 min using various concentrations of DNase I (Worthington, San Francisco, California, United States) to obtain a suitable range of digestion of genomic DNA as revealed by EtBr staining. .. Digested genomic DNA was purified, redigested by RsaI, resolved on a 1.5% agarose gel, and Southern blotted.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99
    Worthington Biochemical dnase i
    Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of <t>DNase</t> I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).
    Dnase I, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 431 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dnase i/product/Worthington Biochemical
    Average 99 stars, based on 431 article reviews
    Price from $9.99 to $1999.99
    dnase i - by Bioz Stars, 2020-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).

    Journal: The EMBO Journal

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    doi: 10.1093/emboj/19.10.2315

    Figure Lengend Snippet: Fig. 2. A constitutive hypersensitive site (3′HS) within the 3′ chromatin boundary. Nuclei from various types of chicken cells were treated with increasing amounts of DNase I (from left to right lanes: 0, 0.06, 0.1, 0.2, 0.4 and 0.6 U/ml for RBCs and brain nuclei; 0, 8.0, 10, 20, 40 and 60 U/ml for DT40 and 6C2 cell nuclei). Genomic DNA was extracted and digested with Kpn I. In addition to a parental fragment, a hypersensitive site, 3′HS, was detected as marked by arrowheads, in all cell types tested. Cells tested are a chicken erythroid precursor derived cell line (6C2), erythroid cells from either 11-day-old embryo (11D RBC) or adult blood (Adult RBC), brain from 11-day-old embryos (Brain) and a lymphoma-cell derived cell line (DT40).

    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Techniques: Derivative Assay

    Fig. 4.  Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with  Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from  Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.

    Journal: The EMBO Journal

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    doi: 10.1093/emboj/19.10.2315

    Figure Lengend Snippet: Fig. 4. Sequences homologous to the 5′ insulator element of the chicken β-globin locus are found at the site of the 3′HS. The position of the 3′HS was measured by the indirect end-labeling method and the strategy is shown in ( A ). Nuclei from 11-day-old chick embryos were treated with 0.4 U/ml DNase I, from which genomic DNA was extracted and digested with Kpn I. In ( B ), the position of the 3′HS (arrow) was compared with the migration of genomic fragments of known length. The 3′HS hypersensitive fragment co-migrates with a fragment derived from Bgl II digestion. ( C ) are found at or close to the sites of 3′HS, 3′HS-A and 3′HS-B, respectively. Alignment of the sequences 3′HS-A and 3′HS-B with the sequences of the 5′FII is shown. Conserved bases are shaded. Bases altered to generate a mutant site are underlined.

    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Techniques: End Labeling, Migration, Derivative Assay, Mutagenesis

    Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.

    Journal: The EMBO Journal

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    doi: 10.1093/emboj/19.10.2315

    Figure Lengend Snippet: Fig. 1. A transition in DNase I sensitivity defines the 3′ boundary of the chicken β-globin domain. The 3′ boundary of generalized DNase I sensitivity is located between regions C and D. ( A ). Restriction fragments A–F detected in DNase I sensitivity assays in (B) are shown below the map. Probes used are indicated as thin lines. A detailed description of DNA fragments A–F and probes is given in Materials and methods. ( B ) Generalized DNase I sensitivity of DNA fragments A–F visualized by Southern blot hybridization. Erythrocyte nuclei isolated from 11-day-old chick embryos were treated with increasing amounts of DNase I (from right to left lanes, 0, 0.2, 0.4, 0.6, 1.0, 2.0 and 5.0 U/ml). Restriction fragments A–F were detected by Southern blot hybridizations. Relative sensitivities to DNase I correspond to the extent of loss of signal intensities of each band. DNA fragments B and C are relatively sensitive to DNase I, while fragments D–F are resistant to DNase I. A DNA fragment derived from the ovalbumin gene, which is transcriptionally inactive in this cell type, and fragment A, which is located farther upstream of the 5′ chromatin boundary, were used as DNase I resistant controls. ( C ) and plotted on a graph: S = log ( G D / G U )/log ( O D / O U ) × T , where G and O are β-globin and ovalbumin band intensities for the undigested (U) or digested (D) samples and T is the size ratio of the ovalbumin to globin fragments. DNase I sensitivity drops significantly between C and D.

    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Techniques: Southern Blot, Hybridization, Isolation, Derivative Assay

    Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.

    Journal: The EMBO Journal

    Article Title: Structural and functional conservation at the boundaries of the chicken ?-globin domain

    doi: 10.1093/emboj/19.10.2315

    Figure Lengend Snippet: Fig. 3. Directional enhancer-blocking activity of the 3′HS. ( A ) The human erythroleukemic cell line K562 was stably transfected with the constructs shown on the left. Each construct has the neomycin resistance gene (NEO) driven by a human β A -globin promoter with mouse β-globin HS2 as an enhancer. The DNA fragments 3′HS and 3′HS-2 include the DNase I HS 3′HS. 3′HS-6 does not contain the HS. For each construct, the 1.2 kb chromatin insulator fragment (5′Ins) including the 5′HS4 was placed upstream of the promoter in order to block influence from regulatory elements at the site of integration. The level of expression of each construct was measured as the number of neomycin-resistant colonies. Colony numbers obtained from construct 1, which does not have a DNA fragment between the promoter and the enhancer, were set at 100. Relative numbers of neomycin-resistant colonies are shown in the bar graph. We present the mean of five independent experiments. Enhancer-blocking activity resides in a DNA fragment containing the 3′HS. ( B ) Enhancer-blocking assays were performed using constructs shown to the left. In construct 1, a 2.3 kb fragment of λ DNA was inserted, as a spacer control, between the enhancer and the reporter. Thick bars show means of at least four independent experiments.

    Article Snippet: The DNase I HS, 3′HS, was detected by digestion of nuclei with increasing amounts of DNase I as above followed by digestion of extracted DNA with Kpn I and probing with i112 (1000 bp; Kpn I –Pst I at 23.3–24.3 map units).

    Techniques: Blocking Assay, Activity Assay, Stable Transfection, Transfection, Construct, Expressing

    DNase I footprinting of protein bound to the I1L promoter. I1L promoter 120-nucleotide DNA uniquely labeled on the template (A) or nontemplate (B) strand was treated with DNase I in the absence (lanes 1) or presence (lanes 2) of glycerol gradient-purified LPBP. Cleavage products were resolved on a 6% polyacrylamide DNA sequencing gel. Lanes 3 contain probe DNA chemically cleaved at purine residues. The nucleotide sequence of each strand of the I1L promoter is shown on the right.

    Journal: Journal of Virology

    Article Title: A Cellular Protein Binds Vaccinia Virus Late Promoters and Activates Transcription In Vitro

    doi:

    Figure Lengend Snippet: DNase I footprinting of protein bound to the I1L promoter. I1L promoter 120-nucleotide DNA uniquely labeled on the template (A) or nontemplate (B) strand was treated with DNase I in the absence (lanes 1) or presence (lanes 2) of glycerol gradient-purified LPBP. Cleavage products were resolved on a 6% polyacrylamide DNA sequencing gel. Lanes 3 contain probe DNA chemically cleaved at purine residues. The nucleotide sequence of each strand of the I1L promoter is shown on the right.

    Article Snippet: DNase I (Worthington Biochemicals) was added to a concentration of 8 ng/ml, and incubation was continued for an additional 2 min, after which the cleavage reaction was terminated by addition of an equal volume of a stop solution (0.2 M NaCl, 30 mM EDTA, 1% sodium dodecyl sulfate, and 100 μg of glycogen/ml).

    Techniques: Footprinting, Labeling, Purification, DNA Sequencing, Sequencing

    Transcription Factor Binding and Nucleosome Depletion at the Human GRP78 Promoter (A) ChIP analysis of the GRP78 promoter was performed on noninduced or TG-induced LD419 cells using antibodies against TBP, RNA polII, NF-Y, total H3, and acetylated H3-K9/14. Precipitated DNA was quantified by real-time PCR using primers specific for the indicated four regions of the promoter. The enrichment at each region is plotted as percentage of input. The data are representatives of experiments performed from two or three independent chromatin preparations. (B, C) MNase assay. (B) A mixture of oligonucleosomes (lane 2) from LD419 nuclei digested with MNase was fractionated through a sucrose gradient to obtain mononucleosomal, dinucleosomal, and trinucleosomal DNA (lanes 4, 5, and 6). Purified genomic DNA partially digested with MNase was used as naked DNA control (D1 and D2, lanes 7 and 8; M in lanes 1 and 9 indicates size marker). (C) Relative enrichment of nucleosomal and naked DNA at four regions of the GRP78 promoter. The values plotted are normalized with respect to the value at the R1 region, arbitrarily defined as 1. The four regions are depicted on the promoter diagram at the top of the figure. The TATA box (T), TIS (bent arrow), and ERSEs (E1–E3) are marked. (D) DNase I hypersensitivity assay. Top: EtBr staining. Bottom: Southern blot. The assay was performed on nuclei extracted from noninduced or TG-induced cells. Genomic DNA was included as a control to show a lack of sequence specificity of the enzyme. DNase I–digested samples were resolved by gel electrophoresis, showing varying extents of digestion (EtBr staining). Southern blot performed after RsaI digestion revealed a hypersensitive region in the GRP78 promoter similar in size in both noninduced and induced samples. On the left, a map of the GRP78 promoter region is shown indicating the 1,802-bp DNA fragment generated by RsaI digestion, transcription start site (bent arrow), and probe fragment (black box). Numbers next to the marker indicate size in bp.

    Journal: PLoS Genetics

    Article Title: Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting

    doi: 10.1371/journal.pgen.0020160

    Figure Lengend Snippet: Transcription Factor Binding and Nucleosome Depletion at the Human GRP78 Promoter (A) ChIP analysis of the GRP78 promoter was performed on noninduced or TG-induced LD419 cells using antibodies against TBP, RNA polII, NF-Y, total H3, and acetylated H3-K9/14. Precipitated DNA was quantified by real-time PCR using primers specific for the indicated four regions of the promoter. The enrichment at each region is plotted as percentage of input. The data are representatives of experiments performed from two or three independent chromatin preparations. (B, C) MNase assay. (B) A mixture of oligonucleosomes (lane 2) from LD419 nuclei digested with MNase was fractionated through a sucrose gradient to obtain mononucleosomal, dinucleosomal, and trinucleosomal DNA (lanes 4, 5, and 6). Purified genomic DNA partially digested with MNase was used as naked DNA control (D1 and D2, lanes 7 and 8; M in lanes 1 and 9 indicates size marker). (C) Relative enrichment of nucleosomal and naked DNA at four regions of the GRP78 promoter. The values plotted are normalized with respect to the value at the R1 region, arbitrarily defined as 1. The four regions are depicted on the promoter diagram at the top of the figure. The TATA box (T), TIS (bent arrow), and ERSEs (E1–E3) are marked. (D) DNase I hypersensitivity assay. Top: EtBr staining. Bottom: Southern blot. The assay was performed on nuclei extracted from noninduced or TG-induced cells. Genomic DNA was included as a control to show a lack of sequence specificity of the enzyme. DNase I–digested samples were resolved by gel electrophoresis, showing varying extents of digestion (EtBr staining). Southern blot performed after RsaI digestion revealed a hypersensitive region in the GRP78 promoter similar in size in both noninduced and induced samples. On the left, a map of the GRP78 promoter region is shown indicating the 1,802-bp DNA fragment generated by RsaI digestion, transcription start site (bent arrow), and probe fragment (black box). Numbers next to the marker indicate size in bp.

    Article Snippet: These were then digested at 37 °C for 15 min using various concentrations of DNase I (Worthington, San Francisco, California, United States) to obtain a suitable range of digestion of genomic DNA as revealed by EtBr staining.

    Techniques: Binding Assay, Chromatin Immunoprecipitation, Real-time Polymerase Chain Reaction, Purification, Marker, Staining, Southern Blot, Sequencing, Nucleic Acid Electrophoresis, Generated